| (+)-alpha-tocopherol | increases activity | ISO | RGD:69168 | 6480464 | alpha-Tocopherol results in increased activity of PPARG protein | CTD | PMID:19083475 |
| (+)-alpha-tocopherol | increases expression | EXP | | 6480464 | alpha-Tocopherol results in increased expression of PPARG protein | CTD | PMID:11752099 |
| (+)-alpha-tocopherol | increases expression | ISO | RGD:69168 | 6480464 | alpha-Tocopherol results in increased expression of PPARG mRNA; more ... | CTD | PMID:14521714 |
| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:69168 | 6480464 | epigallocatechin gallate results in decreased expression of PPARG mRNA | CTD | PMID:20706672 |
| (R)-noradrenaline | increases expression | EXP | | 6480464 | Norepinephrine results in increased expression of PPARG mRNA | CTD | PMID:19109942 |
| 1,3-thiazolidine-2,4-dione | increases expression | EXP | | 6480464 | 2,4-thiazolidinedione results in increased expression of PPARG mRNA | CTD | PMID:20724125 |
| 1,3-thiazolidine-2,4-dione | multiple interactions | ISO | RGD:69168 | 6480464 | 2,4-thiazolidinedione binds to and results in increased activity of PPARG protein | CTD | PMID:15521013 |
| 1,3-thiazolidine-2,4-dione | affects binding | ISO | RGD:69168 | 6480464 | 2,4-thiazolidinedione binds to PPARG protein | CTD | PMID:15916743 |
| 1,4-phenylenediamine | increases expression | ISO | RGD:69168 | 6480464 | 4-phenylenediamine results in increased expression of PPARG mRNA | CTD | PMID:16314067 |
| 17-HDoHE | multiple interactions | ISO | RGD:69169 | 6480464 | 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid binds to and affects the activity of PPARG protein | CTD | PMID:17056761 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69168 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | increases expression | ISO | RGD:69168 | 6480464 | Estradiol results in increased expression of PPARG mRNA | CTD | PMID:19619570 PMID:21185374 |
| 17beta-estradiol | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]] | CTD | PMID:21734263 |
| 17beta-estradiol | increases expression | ISO | RGD:69169 | 6480464 | Estradiol results in increased expression of PPARG mRNA | CTD | PMID:18359623 |
| 17beta-estradiol | decreases expression | ISO | RGD:69168 | 6480464 | Estradiol results in decreased expression of PPARG mRNA | CTD | PMID:21632903 |
| 17beta-estradiol | increases expression | ISO | RGD:69168 | 6480464 | Estradiol results in increased expression of PPARG mRNA | CTD | PMID:19619570 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:69168 | 6480464 | Dihydrotestosterone results in decreased expression of PPARG protein; more ... | CTD | PMID:18801408 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:69169 | 6480464 | Dihydrotestosterone results in increased expression of PPARG mRNA | CTD | PMID:16990341 |
| 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | RGD:69169 | 6480464 | Dihydrotestosterone results in decreased expression of PPARG mRNA; more ... | CTD | PMID:12960001 |
| 1H-pyrazole | increases expression | ISO | RGD:69169 | 6480464 | pyrazole results in increased expression of PPARG mRNA | CTD | PMID:17945193 |
| 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononanoic acid | increases expression | ISO | RGD:69169 | 6480464 | hexadecafluoro-nonanoic acid results in increased expression of PPARG mRNA | CTD | PMID:18583369 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | [Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]; more ... | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:12758056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]; more ... | CTD | PMID:16971554 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69168 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA | CTD | PMID:19619570 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:12758056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | [NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PPARG mRNA | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:19063610 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:12758056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG protein | CTD | PMID:12758056 PMID:15050417 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:12758056 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69168 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA | CTD | PMID:20106945 PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:19063610 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | PD 98059 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] | CTD | PMID:15050417 PMID:12758056 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]] | CTD | PMID:14505802 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | PD 98059 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] | CTD | PMID:12758056 PMID:15050417 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]; more ... | CTD | PMID:12758056 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:19063610 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69169 | 6480464 | 3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein] | CTD | PMID:15050417 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:69168 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA | CTD | PMID:19619570 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:69168 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG protein | CTD | PMID:15050417 PMID:12758056 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69169 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA | CTD | PMID:12758056 more ... |
| 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]; more ... | CTD | PMID:16782535 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | ISO | RGD:69169 | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA | CTD | PMID:21829567 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein | CTD | PMID:16782535 PMID:19617644 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein | CTD | PMID:19617644 PMID:16782535 |
| 2,4,6-trinitrobenzenesulfonic acid | decreases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA; more ... | CTD | PMID:16782535 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | RGD:69169 | 6480464 | Butylated Hydroxytoluene results in increased expression of PPARG mRNA | CTD | PMID:19925653 |
| 2,6-di-tert-butyl-4-methylphenol | multiple interactions | ISO | RGD:69168 | 6480464 | Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA] | CTD | PMID:17070507 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:69168 | 6480464 | Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] | CTD | PMID:22089456 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of PPARG mRNA | CTD | PMID:15694357 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:69169 | 6480464 | Glucosamine results in increased expression of PPARG mRNA | CTD | PMID:15694357 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:69168 | 6480464 | Glucosamine results in increased expression of PPARG | CTD | PMID:22089456 |
| 2-arachidonoylglycerol | affects binding | ISO | RGD:69168 | 6480464 | 2-arachidonylglycerol metabolite binds to PPARG protein | CTD | PMID:21511917 |
| 2-arachidonoylglycerol | multiple interactions | ISO | RGD:69168 | 6480464 | T 0070907 inhibits the reaction [2-arachidonylglycerol metabolite results in increased expression of PPARG mRNA] | CTD | PMID:21511917 |
| 2-arachidonoylglycerol | increases expression | ISO | RGD:69168 | 6480464 | 2-arachidonylglycerol metabolite results in increased expression of PPARG mRNA | CTD | PMID:21511917 |
| 2-deoxy-D-glucose | affects uptake | ISO | RGD:69169 | 6480464 | PPARG protein affects the uptake of Deoxyglucose | CTD | PMID:18083318 |
| 2-deoxy-D-glucose | increases uptake | ISO | RGD:69169 | 6480464 | PPARG gene polymorphism results in increased uptake of Deoxyglucose | CTD | PMID:18083318 |
| 25-hydroxycholesterol | multiple interactions | ISO | RGD:69168 | 6480464 | [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]; more ... | CTD | PMID:12595494 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | EXP | | 6480464 | pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein] | CTD | PMID:16598202 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | EXP | | 6480464 | Puromycin Aminonucleoside results in increased expression of PPARG protein | CTD | PMID:16598202 |
| 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | RGD:69168 | 6480464 | tetrabromobisphenol A binds to and results in increased activity of PPARG protein; more ... | CTD | PMID:21622942 |
| 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | RGD:69168 | 6480464 | tetrabromobisphenol A binds to and results in increased activity of PPARG protein | CTD | PMID:21561829 more ... |
| 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | RGD:69168 | 6480464 | tetrabromobisphenol A binds to and results in increased activity of PPARG protein | CTD | PMID:21561829 PMID:21622942 |
| 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | RGD:69168 | 6480464 | tetrabromobisphenol A binds to and results in increased activity of PPARG protein | CTD | PMID:21622942 PMID:21561829 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69169 | 6480464 | AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]; more ... | CTD | PMID:16971554 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:23152186 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69168 | 6480464 | aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] | CTD | PMID:22645054 |
| 3-isobutyl-1-methyl-7H-xanthine | increases expression | ISO | RGD:69168 | 6480464 | 1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA | CTD | PMID:22645054 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69169 | 6480464 | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]; more ... | CTD | PMID:22197818 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69168 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA; more ... | CTD | PMID:19186324 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA | CTD | PMID:21350315 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69169 | 6480464 | [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein; more ... | CTD | PMID:11101056 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:16054899 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69169 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA]; more ... | CTD | PMID:19141685 |
| 3-isobutyl-1-methyl-7H-xanthine | increases expression | ISO | RGD:69169 | 6480464 | 1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA | CTD | PMID:19141685 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:20206132 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:69169 | 6480464 | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; more ... | CTD | PMID:22298784 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | RGD:69169 | 6480464 | Oxazolone results in increased expression of PPARG protein | CTD | PMID:22200888 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | multiple interactions | ISO | RGD:69169 | 6480464 | tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein] | CTD | PMID:22200888 |
| 4-coumaric acid | increases expression | ISO | RGD:69169 | 6480464 | 4-coumaric acid results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| 4-hydroxyphenyl retinamide | increases activity | ISO | RGD:69168 | 6480464 | Fenretinide results in increased activity of PPARG protein | CTD | PMID:16274795 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:69168 | 6480464 | decitabine results in increased expression of PPARG mRNA | CTD | PMID:16763620 |
| 5-azacytidine | decreases methylation | ISO | RGD:69169 | 6480464 | Azacitidine results in decreased methylation of PPARG promoter | CTD | PMID:19589179 |
| 5-azacytidine | increases expression | ISO | RGD:69169 | 6480464 | Azacitidine results in increased expression of PPARG mRNA | CTD | PMID:19589179 |
| 5-fluorouracil | decreases expression | ISO | RGD:69168 | 6480464 | Fluorouracil results in decreased expression of PPARG protein | CTD | PMID:15352031 |
| 5-fluorouracil | affects response to substance | ISO | RGD:69168 | 6480464 | PPARG protein affects the susceptibility to Fluorouracil | CTD | PMID:15352031 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA | CTD | PMID:15994020 |
| 8-bromo-3',5'-cyclic AMP | multiple interactions | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA] | CTD | PMID:15994020 |
| 9,11,13-octadecatrienoic acid | increases expression | ISO | RGD:69168 | 6480464 | eleostearic acid results in increased expression of PPARG mRNA; more ... | CTD | PMID:15961301 |
| 9-cis-retinoic acid | increases activity | ISO | RGD:69168 | 6480464 | alitretinoin results in increased activity of PPARG protein | CTD | PMID:15707588 |
| 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | alitretinoin binds to and results in increased activity of PPARG protein | CTD | PMID:18063688 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein promotes the reaction [alitretinoin results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 |
| 9-cis-retinoic acid | multiple interactions | EXP | | 6480464 | [9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] | CTD | PMID:15150131 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:69169 | 6480464 | [pioglitazone co-treated with alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine] | CTD | PMID:17019405 |
| 9-cis-retinoic acid | multiple interactions | ISO | RGD:69168 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [alitretinoin results in increased activity of PPARG protein]; more ... | CTD | PMID:15707588 |
| AACOCF3 | multiple interactions | ISO | RGD:69169 | 6480464 | arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] | CTD | PMID:19063610 |
| acetaldehyde | multiple interactions | ISO | RGD:69168 | 6480464 | ABL1 protein promotes the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]; more ... | CTD | PMID:17030193 |
| acetylsalicylic acid | decreases activity | ISO | RGD:69168 | 6480464 | Aspirin results in decreased activity of PPARG protein | CTD | PMID:15646027 |
| acetylsalicylic acid | decreases expression | EXP | | 6480464 | Aspirin results in decreased expression of PPARG mRNA | CTD | PMID:18222077 |
| acetylsalicylic acid | increases expression | ISO | RGD:69169 | 6480464 | Aspirin results in increased expression of PPARG mRNA | CTD | PMID:19462226 |
| acetylsalicylic acid | increases expression | ISO | RGD:69168 | 6480464 | Aspirin results in increased expression of PPARG protein; more ... | CTD | PMID:19880272 |
| acetylsalicylic acid | increases expression | ISO | RGD:69168 | 6480464 | Aspirin results in increased expression of PPARG | CTD | PMID:18971601 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:69168 | 6480464 | Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein] | CTD | PMID:16386710 |
| aflatoxin B1 | increases expression | ISO | RGD:69169 | 6480464 | Aflatoxin B1 results in increased expression of PPARG mRNA | CTD | PMID:19770486 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:69168 | 6480464 | Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] | CTD | PMID:22089456 |
| aldehydo-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of PPARG mRNA | CTD | PMID:15694357 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:69169 | 6480464 | Glucosamine results in increased expression of PPARG mRNA | CTD | PMID:15694357 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:69168 | 6480464 | Glucosamine results in increased expression of PPARG | CTD | PMID:22089456 |
| aldehydo-D-glucosamine 6-phosphate | decreases expression | ISO | RGD:69169 | 6480464 | glucosamine 6-phosphate results in decreased expression of PPARG protein | CTD | PMID:19427183 |
| aldosterone | affects abundance | ISO | RGD:69169 | 6480464 | PPARG protein affects the abundance of Aldosterone | CTD | PMID:16007095 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:69168 | 6480464 | [PPARG protein results in increased expression of ALDH1A2 protein] which results in increased chemical synthesis of Tretinoin; more ... | CTD | PMID:16982809 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69168 | 6480464 | Tretinoin results in increased expression of PPARG mRNA | CTD | PMID:21934132 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of PPARG mRNA; more ... | CTD | PMID:14568882 |
| all-trans-retinoic acid | increases expression | ISO | RGD:69169 | 6480464 | Tretinoin results in increased expression of PPARG mRNA | CTD | PMID:17198874 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:69169 | 6480464 | Tretinoin results in decreased expression of PPARG mRNA | CTD | PMID:11237167 |
| all-trans-retinol | multiple interactions | EXP | | 6480464 | Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA] | CTD | PMID:15203375 |
| all-trans-retinol | increases expression | EXP | | 6480464 | Vitamin A results in increased expression of PPARG mRNA | CTD | PMID:16180333 |
| allethrin | increases activity | ISO | RGD:69168 | 6480464 | Allethrin results in increased activity of PPARG protein | CTD | PMID:20143881 |
| alpha-linolenic acid | increases expression | ISO | RGD:69169 | 6480464 | alpha-Linolenic Acid results in increased expression of PPARG mRNA | CTD | PMID:18154422 |
| alpha-linolenic acid | increases activity | ISO | RGD:69168 | 6480464 | alpha-Linolenic Acid results in increased activity of PPARG protein | CTD | PMID:20696231 |
| alpha-linolenic acid | multiple interactions | ISO | RGD:69168 | 6480464 | alpha-Linolenic Acid binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 |
| alpha-linolenic acid | multiple interactions | ISO | RGD:69169 | 6480464 | alpha-Linolenic Acid binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 |
| alpha-linolenic acid | multiple interactions | EXP | | 6480464 | alpha-Linolenic Acid binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 |
| aminoguanidine | multiple interactions | EXP | | 6480464 | pimagedine inhibits the reaction [Glycosylation End Products, Advanced results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:17264099 |
| amiodarone | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of SCD mRNA]; more ... | CTD | PMID:21123845 |
| amiodarone | increases expression | ISO | RGD:69168 | 6480464 | Amiodarone results in increased expression of PPARG mRNA | CTD | PMID:21123845 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of PPARG mRNA | CTD | PMID:16483693 |
| apigenin | multiple interactions | ISO | RGD:69169 | 6480464 | Apigenin binds to and results in increased activity of PPARG protein; more ... | CTD | PMID:11343698 |
| apigenin | decreases expression | ISO | RGD:69169 | 6480464 | Apigenin results in decreased expression of PPARG mRNA | CTD | PMID:18359623 |
| arachidonic acid | multiple interactions | ISO | RGD:69169 | 6480464 | Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA] | CTD | PMID:19063610 |
| arachidonic acid | increases expression | EXP | | 6480464 | Arachidonic Acid results in increased expression of PPARG protein | CTD | PMID:12604186 |
| arachidonic acid | decreases expression | ISO | RGD:69168 | 6480464 | Arachidonic Acid results in decreased expression of PPARG mRNA; more ... | CTD | PMID:11172467 |
| Aroclor 1254 | increases expression | ISO | RGD:69168 | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of PPARG mRNA | CTD | PMID:16934159 |
| arsenic atom | decreases expression | ISO | RGD:69168 | 6480464 | Arsenic results in decreased expression of PPARG mRNA; more ... | CTD | PMID:23108036 |
| arsenic atom | multiple interactions | ISO | RGD:69168 | 6480464 | Arsenic inhibits the reaction [CEBPB protein binds to PPARG protein]; more ... | CTD | PMID:23108036 |
| arsenite(3-) | increases expression | ISO | RGD:69169 | 6480464 | arsenite results in increased expression of PPARG mRNA | CTD | PMID:15868481 |
| atrazine | multiple interactions | ISO | RGD:69168 | 6480464 | [Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA | CTD | PMID:18585445 |
| azelaic acid | increases activity | ISO | RGD:69168 | 6480464 | azelaic acid results in increased activity of PPARG protein | CTD | PMID:20545756 |
| azelaic acid | increases expression | ISO | RGD:69168 | 6480464 | azelaic acid results in increased expression of PPARG mRNA | CTD | PMID:20545756 |
| benzbromarone | affects expression | ISO | RGD:69169 | 6480464 | Benzbromarone affects the expression of PPARG mRNA | CTD | PMID:19048458 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69168 | 6480464 | Benzo(a)pyrene results in decreased expression of PPARG mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of PPARG mRNA | CTD | PMID:20920559 PMID:22374506 |
| benzo[a]pyrene | increases expression | ISO | RGD:69169 | 6480464 | Benzo(a)pyrene results in increased expression of PPARG mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69169 | 6480464 | Benzo(a)pyrene results in decreased expression of PPARG mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of PPARG mRNA; more ... | CTD | PMID:20920559 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69169 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of PPARG mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:69169 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] | CTD | PMID:19141685 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA; more ... | CTD | PMID:20920559 |
| benzo[a]pyrene | increases expression | ISO | RGD:69168 | 6480464 | Benzo(a)pyrene results in increased expression of PPARG mRNA | CTD | PMID:15735009 |
| berberine | multiple interactions | ISO | RGD:69169 | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]; more ... | CTD | PMID:20564506 |
| beta-carotene | decreases expression | ISO | RGD:69169 | 6480464 | beta Carotene results in decreased expression of PPARG mRNA | CTD | PMID:21569430 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:69168 | 6480464 | Glucosamine promotes the reaction [IL1B results in increased expression of PPARG] | CTD | PMID:22089456 |
| beta-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of PPARG mRNA | CTD | PMID:15694357 |
| beta-D-glucosamine | increases expression | ISO | RGD:69169 | 6480464 | Glucosamine results in increased expression of PPARG mRNA | CTD | PMID:15694357 |
| beta-D-glucosamine | increases expression | ISO | RGD:69168 | 6480464 | Glucosamine results in increased expression of PPARG | CTD | PMID:22089456 |
| bezafibrate | increases expression | ISO | RGD:69169 | 6480464 | Bezafibrate results in increased expression of PPARG mRNA | CTD | PMID:21324916 PMID:19201410 |
| bezafibrate | increases expression | ISO | RGD:69169 | 6480464 | Bezafibrate results in increased expression of PPARG mRNA | CTD | PMID:19201410 PMID:21324916 |
| bezafibrate | increases activity | ISO | RGD:69169 | 6480464 | Bezafibrate results in increased activity of PPARG protein | CTD | PMID:12401884 |
| bezafibrate | increases expression | ISO | RGD:69168 | 6480464 | Bezafibrate results in increased expression of PPARG mRNA | CTD | PMID:19201410 |
| bezafibrate | multiple interactions | ISO | RGD:69168 | 6480464 | Bezafibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein] | CTD | PMID:11779144 |
| bezafibrate | decreases expression | ISO | RGD:69168 | 6480464 | Bezafibrate results in decreased expression of PPARG mRNA | CTD | PMID:15708366 |
| bezafibrate | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]; more ... | CTD | PMID:21734263 |
| bezafibrate | affects binding | ISO | RGD:69168 | 6480464 | Bezafibrate binds to PPARG protein | CTD | PMID:11779144 |
| bezafibrate | multiple interactions | EXP | | 6480464 | Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] | CTD | PMID:12967931 |
| bezafibrate | decreases expression | EXP | | 6480464 | Bezafibrate results in decreased expression of PPARG mRNA | CTD | PMID:11473052 |
| bezafibrate | multiple interactions | ISO | RGD:69169 | 6480464 | PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA] | CTD | PMID:21324916 |
| bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA; more ... | CTD | PMID:20920559 |
| bis(2-ethylhexyl) phthalate | affects expression | ISO | RGD:69169 | 6480464 | Diethylhexyl Phthalate affects the expression of PPARG mRNA | CTD | PMID:22588786 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of PPARG protein | CTD | PMID:15647598 more ... |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:69169 | 6480464 | Diethylhexyl Phthalate results in increased expression of PPARG protein | CTD | PMID:21856391 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:69169 | 6480464 | Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form] | CTD | PMID:22197818 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of PPARG protein; more ... | CTD | PMID:15647598 PMID:20920559 |
| bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of PPARG protein; more ... | CTD | PMID:20920559 PMID:15647598 |
| bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of PPARG protein | CTD | PMID:16690193 |
| bisdemethoxycurcumin | affects binding | ISO | RGD:69168 | 6480464 | bis(4-hydroxycinnamoyl)methane binds to PPARG protein | CTD | PMID:15713005 |
| bisphenol A | increases expression | ISO | RGD:69168 | 6480464 | bisphenol A results in increased expression of PPARG mRNA | CTD | PMID:20064783 |
| bisphenol A | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA] | CTD | PMID:23399309 |
| bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PPARG mRNA | CTD | PMID:23399309 |
| bisphenol A | increases expression | ISO | RGD:69168 | 6480464 | bisphenol A results in increased expression of PPARG mRNA | CTD | PMID:20064783 PMID:23090578 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PPARG mRNA | CTD | PMID:20019905 |
| bisphenol A | increases expression | ISO | RGD:69169 | 6480464 | bisphenol A results in increased expression of PPARG mRNA | CTD | PMID:18359623 |
| bisphenol A | multiple interactions | ISO | RGD:69168 | 6480464 | bisphenol A analog binds to and results in increased activity of PPARG protein; more ... | CTD | PMID:21622942 |
| bisphenol A | increases expression | ISO | RGD:69169 | 6480464 | bisphenol A results in increased expression of PPARG mRNA | CTD | PMID:18359623 PMID:21932408 |
| bisphenol A | increases expression | ISO | RGD:69169 | 6480464 | bisphenol A results in increased expression of PPARG mRNA | CTD | PMID:21932408 PMID:18359623 |
| bisphenol A | multiple interactions | ISO | RGD:69169 | 6480464 | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form] | CTD | PMID:22197818 |
| bisphenol A | increases localization | ISO | RGD:69168 | 6480464 | bisphenol A results in increased localization of PPARG protein | CTD | PMID:20064783 |
| bleomycin A2 | decreases expression | ISO | RGD:69169 | 6480464 | Bleomycin results in decreased expression of PPARG mRNA | CTD | PMID:19147827 |
| bleomycin A2 | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA] | CTD | PMID:19147827 |
| butyric acid | increases expression | ISO | RGD:69168 | 6480464 | Butyric Acid results in increased expression of PPARG mRNA; more ... | CTD | PMID:10833422 |
| cadmium atom | decreases expression | ISO | RGD:69169 | 6480464 | Cadmium results in decreased expression of PPARG protein | CTD | PMID:21848503 |
| cadmium sulfate | multiple interactions | ISO | RGD:69169 | 6480464 | cadmium sulfate affects the reaction [MTF1 affects the expression of PPARG mRNA] | CTD | PMID:16221973 |
| calcitriol | decreases expression | ISO | RGD:69169 | 6480464 | Calcitriol results in decreased expression of PPARG protein | CTD | PMID:15036392 |
| calcitriol | decreases expression | ISO | RGD:69169 | 6480464 | Calcitriol results in decreased expression of PPARG mRNA | CTD | PMID:15036392 more ... |
| calcitriol | decreases expression | ISO | RGD:69169 | 6480464 | Calcitriol results in decreased expression of PPARG mRNA | CTD | PMID:15036392 more ... |
| calcitriol | decreases expression | ISO | RGD:69169 | 6480464 | Calcitriol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 more ... |
| calcitriol | decreases expression | ISO | RGD:69169 | 6480464 | Calcitriol results in decreased expression of PPARG mRNA | CTD | PMID:16368784 more ... |
| calcitriol | decreases expression | ISO | RGD:69169 | 6480464 | Calcitriol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 more ... |
| caprylic acid | multiple interactions | ISO | RGD:69169 | 6480464 | [caprylic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form; more ... | CTD | PMID:14984747 |
| capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] | CTD | PMID:20359164 |
| capsaicin | increases activity | ISO | RGD:69168 | 6480464 | Capsaicin results in increased activity of PPARG protein | CTD | PMID:15383218 |
| capsaicin | decreases expression | ISO | RGD:69169 | 6480464 | Capsaicin results in decreased expression of PPARG protein | CTD | PMID:17295509 |
| capsaicin | decreases expression | ISO | RGD:69168 | 6480464 | Capsaicin results in decreased expression of PPARG mRNA | CTD | PMID:18769453 |
| capsaicin | multiple interactions | ISO | RGD:69168 | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein] | CTD | PMID:15383218 |
| carbon monoxide | multiple interactions | ISO | RGD:69169 | 6480464 | [Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein; more ... | CTD | PMID:22046279 |
| carnosic acid | increases activity | ISO | RGD:69168 | 6480464 | salvin results in increased activity of PPARG protein | CTD | PMID:20696231 |
| carotenoid | decreases expression | ISO | RGD:69169 | 6480464 | Carotenoids results in decreased expression of PPARG mRNA | CTD | PMID:11237167 |
| celecoxib | multiple interactions | ISO | RGD:69168 | 6480464 | [celecoxib results in decreased activity of and results in decreased expression of PTGS2 protein] which results in increased expression of PPARG | CTD | PMID:19522023 |
| celecoxib | increases expression | EXP | | 6480464 | celecoxib results in increased expression of PPARG mRNA | CTD | PMID:12960143 |
| celecoxib | multiple interactions | EXP | | 6480464 | celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] | CTD | PMID:19247274 |
| celecoxib | multiple interactions | ISO | RGD:69169 | 6480464 | [celecoxib co-treated with docetaxel] results in increased expression of PPARG protein | CTD | PMID:16052515 |
| cerulenin | decreases expression | ISO | RGD:69169 | 6480464 | Cerulenin results in decreased expression of PPARG mRNA | CTD | PMID:15707987 |
| ceruletide | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG affects the reaction [Caerulein results in increased expression of CXCL1 mRNA]; more ... | CTD | PMID:17463185 |
| chenodeoxycholic acid | increases expression | EXP | | 6480464 | Chenodeoxycholic Acid results in increased expression of PPARG mRNA | CTD | PMID:15980055 |
| chlorogenic acid | increases expression | ISO | RGD:69169 | 6480464 | Chlorogenic Acid results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| chlorogenic acid | decreases expression | ISO | RGD:69168 | 6480464 | Chlorogenic Acid results in decreased expression of PPARG mRNA | CTD | PMID:20706672 |
| cholesterol | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol] | CTD | PMID:20372816 |
| cholesterol | multiple interactions | ISO | RGD:69168 | 6480464 | [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol]; more ... | CTD | PMID:12595494 |
| cholesterol | multiple interactions | ISO | RGD:69169 | 6480464 | [Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA; more ... | CTD | PMID:18302760 |
| cholesterol | multiple interactions | ISO | RGD:69168 | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of Cholesterol; more ... | CTD | PMID:16946405 |
| cholesterol | multiple interactions | ISO | RGD:69168 | 6480464 | Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol] | CTD | PMID:12044893 |
| cholesterol | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein promotes the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]] | CTD | PMID:19797938 |
| choline | multiple interactions | ISO | RGD:69169 | 6480464 | [Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA; more ... | CTD | PMID:18991162 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:12604364 more ... |
| ciglitazone | decreases response to substance | ISO | RGD:69168 | 6480464 | PPARG protein mutant form results in decreased susceptibility to ciglitazone | CTD | PMID:19922793 |
| ciglitazone | increases expression | ISO | RGD:69168 | 6480464 | ciglitazone results in increased expression of PPARG mRNA | CTD | PMID:11278336 more ... |
| ciglitazone | increases expression | ISO | RGD:69168 | 6480464 | ciglitazone results in increased expression of PPARG mRNA | CTD | PMID:11840453 more ... |
| ciglitazone | affects binding | ISO | RGD:69168 | 6480464 | ciglitazone binds to PPARG protein | CTD | PMID:12839938 PMID:21511917 |
| ciglitazone | increases localization | ISO | RGD:69168 | 6480464 | ciglitazone results in increased localization of PPARG protein | CTD | PMID:12517972 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:11030710 more ... |
| ciglitazone | increases activity | ISO | RGD:69168 | 6480464 | ciglitazone results in increased activity of PPARG protein | CTD | PMID:12517972 more ... |
| ciglitazone | multiple interactions | EXP | | 6480464 | ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein] | CTD | PMID:16820301 |
| ciglitazone | increases expression | ISO | RGD:69168 | 6480464 | ciglitazone results in increased expression of PPARG mRNA | CTD | PMID:14512786 PMID:11840453 |
| ciglitazone | increases activity | ISO | RGD:69168 | 6480464 | ciglitazone results in increased activity of PPARG protein | CTD | PMID:21543282 more ... |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15187150 more ... |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:12604364 more ... |
| ciglitazone | increases activity | ISO | RGD:69169 | 6480464 | ciglitazone results in increased activity of PPARG protein | CTD | PMID:11683414 PMID:16023420 |
| ciglitazone | increases activity | ISO | RGD:69168 | 6480464 | ciglitazone results in increased activity of PPARG protein | CTD | PMID:16417216 PMID:16386710 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16326050 more ... |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15866424 more ... |
| ciglitazone | multiple interactions | EXP | | 6480464 | [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose | CTD | PMID:18063688 |
| ciglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein promotes the reaction [ciglitazone results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 |
| ciglitazone | increases activity | ISO | RGD:69169 | 6480464 | ciglitazone results in increased activity of PPARG protein | CTD | PMID:16023420 PMID:11683414 |
| ciglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | ciglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine] | CTD | PMID:17019405 |
| ciglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15187150 PMID:12847270 |
| ciglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]] | CTD | PMID:12847270 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]] | CTD | PMID:12839938 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein]; more ... | CTD | PMID:18393431 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein] | CTD | PMID:16326050 |
| ciglitazone | increases expression | ISO | RGD:69168 | 6480464 | ciglitazone results in increased expression of PPARG mRNA | CTD | PMID:11840453 PMID:14512786 |
| ciglitazone | increases expression | ISO | RGD:69168 | 6480464 | ciglitazone results in increased expression of PPARG protein | CTD | PMID:21067863 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]; more ... | CTD | PMID:11840453 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA] | CTD | PMID:12604364 |
| ciglitazone | increases activity | ISO | RGD:69168 | 6480464 | ciglitazone results in increased activity of PPARG protein | CTD | PMID:16386710 PMID:16417216 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ABHD3 mRNA; more ... | CTD | PMID:16197558 |
| ciglitazone | affects binding | ISO | RGD:69168 | 6480464 | ciglitazone binds to PPARG protein | CTD | PMID:12839938 |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:18162602 more ... |
| ciglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | ciglitazone binds to and results in decreased activity of PPARG protein | CTD | PMID:12391285 |
| ciglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | ciglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:12847270 PMID:15187150 |
| ciglitazone | increases activity | ISO | RGD:69168 | 6480464 | ciglitazone results in increased activity of PPARG protein | CTD | PMID:16386710 more ... |
| cilostazol | increases activity | ISO | RGD:69168 | 6480464 | cilostazol results in increased activity of PPARG protein | CTD | PMID:21660147 |
| cilostazol | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [cilostazol results in increased activity of PPARG protein]; more ... | CTD | PMID:21660147 |
| cinnamic acid | increases expression | ISO | RGD:69169 | 6480464 | cinnamic acid results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| cis-caffeic acid | increases expression | ISO | RGD:69169 | 6480464 | caffeic acid results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| cisplatin | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Cisplatin; more ... | CTD | PMID:21781307 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of PPARG mRNA | CTD | PMID:22989705 |
| cisplatin | multiple interactions | EXP | | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:22989705 |
| clofibrate | multiple interactions | ISO | RGD:69169 | 6480464 | [Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA; more ... | CTD | PMID:9543393 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of PPARG protein | CTD | PMID:12604186 PMID:12699904 |
| clofibrate | multiple interactions | EXP | | 6480464 | PPARG protein promotes the reaction [Clofibrate results in decreased expression of ALDH3A1 mRNA] | CTD | PMID:12604186 |
| clofibrate | affects response to substance | EXP | | 6480464 | PPARG protein affects the susceptibility to Clofibrate | CTD | PMID:12604186 |
| clofibrate | multiple interactions | ISO | RGD:69168 | 6480464 | Clofibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein] | CTD | PMID:11779144 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of PPARG protein | CTD | PMID:12699904 PMID:12604186 |
| clofibrate | increases response to substance | EXP | | 6480464 | PPARG results in increased susceptibility to Clofibrate | CTD | PMID:12699904 |
| clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of PPARG mRNA; more ... | CTD | PMID:12699904 |
| clofibric acid | affects binding | ISO | RGD:69168 | 6480464 | Clofibric Acid binds to PPARG protein | CTD | PMID:11779144 |
| clozapine | multiple interactions | ISO | RGD:69169 | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]; more ... | CTD | PMID:20564506 |
| clozapine | increases expression | ISO | RGD:69169 | 6480464 | Clozapine results in increased expression of PPARG mRNA; more ... | CTD | PMID:20564506 |
| cobalt dichloride | decreases expression | ISO | RGD:69168 | 6480464 | cobaltous chloride results in decreased expression of PPARG mRNA | CTD | PMID:15708366 |
| cobalt dichloride | decreases expression | ISO | RGD:69169 | 6480464 | cobaltous chloride results in decreased expression of PPARG mRNA | CTD | PMID:20594416 |
| curcumin | affects binding | ISO | RGD:69168 | 6480464 | Curcumin binds to PPARG protein | CTD | PMID:15713005 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG protein; more ... | CTD | PMID:16959952 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG mRNA | CTD | PMID:17531121 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG protein | CTD | PMID:17602960 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG mRNA | CTD | PMID:16959952 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG protein | CTD | PMID:17602960 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG protein; more ... | CTD | PMID:18332871 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG mRNA | CTD | PMID:18332871 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG mRNA | CTD | PMID:17602960 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG protein | CTD | PMID:17531121 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG mRNA | CTD | PMID:16959952 more ... |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of PPARG protein | CTD | PMID:16959952 more ... |
| curcumin | increases activity | EXP | | 6480464 | Curcumin results in increased activity of PPARG protein | CTD | PMID:18332871 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of PPARG protein | CTD | PMID:19225048 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:16959952 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:16782535 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:17372590 |
| curcumin | affects localization | EXP | | 6480464 | Curcumin affects the localization of PPARG protein | CTD | PMID:17531121 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] | CTD | PMID:18006644 |
| curcumin | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]; more ... | CTD | PMID:17602960 |
| curcumin | multiple interactions | ISO | RGD:69169 | 6480464 | Curcumin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA] | CTD | PMID:19297423 |
| curcumin | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]; more ... | CTD | PMID:17531121 |
| curcumin | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [Curcumin results in decreased expression of CTGF mRNA] | CTD | PMID:17965732 |
| curcumin | increases activity | ISO | RGD:69168 | 6480464 | Curcumin results in increased activity of PPARG protein | CTD | PMID:15486348 |
| curcumin | decreases expression | ISO | RGD:69168 | 6480464 | Curcumin results in decreased expression of PPARG protein modified form | CTD | PMID:15486348 |
| cyanamide | multiple interactions | ISO | RGD:69168 | 6480464 | Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] | CTD | PMID:17030193 |
| cyclosporin A | multiple interactions | ISO | RGD:69168 | 6480464 | [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein | CTD | PMID:17016853 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of PPARG mRNA; more ... | CTD | PMID:17461532 |
| cyclosporin A | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]; more ... | CTD | PMID:17461532 |
| cyclosporin A | increases expression | ISO | RGD:69168 | 6480464 | Cyclosporine results in increased expression of PPARG mRNA | CTD | PMID:20106945 |
| cytarabine | multiple interactions | ISO | RGD:69169 | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA] | CTD | PMID:23264188 |
| cytarabine | increases expression | ISO | RGD:69169 | 6480464 | Cytarabine results in increased expression of PPARG mRNA | CTD | PMID:23264188 |
| D-glucose | multiple interactions | EXP | | 6480464 | [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose | CTD | PMID:18063688 |
| D-glucose | decreases expression | ISO | RGD:69168 | 6480464 | Glucose results in decreased expression of PPARG protein | CTD | PMID:21333731 |
| D-glucose | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] | CTD | PMID:21333731 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of PPARG protein; more ... | CTD | PMID:19609456 |
| D-glucose | multiple interactions | EXP | | 6480464 | PPARG protein inhibits the reaction [Glucose results in increased secretion of INS1 protein] | CTD | PMID:15878969 |
| daunorubicin | multiple interactions | EXP | | 6480464 | telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] | CTD | PMID:20888384 |
| daunorubicin | increases expression | EXP | | 6480464 | Daunorubicin results in increased expression of PPARG protein | CTD | PMID:20888384 |
| DDT | multiple interactions | ISO | RGD:69169 | 6480464 | DDT results in increased activity of and results in increased localization of PPARG protein | CTD | PMID:11911853 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | ISO | RGD:69168 | 6480464 | [RXRA co-treated with Tetrahydrocannabinol] results in increased expression of PPARG mRNA | CTD | PMID:16213464 |
| demethoxycurcumin | affects binding | ISO | RGD:69168 | 6480464 | demethoxycurcumin binds to PPARG protein | CTD | PMID:15713005 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]; more ... | CTD | PMID:22298784 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | butylparaben promotes the reaction [Dexamethasone results in increased expression of PPARG mRNA] | CTD | PMID:22956630 |
| dexamethasone | increases expression | ISO | RGD:69169 | 6480464 | Dexamethasone results in increased expression of PPARG mRNA | CTD | PMID:22956630 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:23152186 |
| dexamethasone | increases expression | ISO | RGD:69168 | 6480464 | Dexamethasone results in increased expression of PPARG mRNA | CTD | PMID:16569937 PMID:19853017 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | [INS1 protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA; more ... | CTD | PMID:11812925 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of PPARG mRNA | CTD | PMID:14568882 PMID:19118567 |
| dexamethasone | increases expression | ISO | RGD:69169 | 6480464 | Dexamethasone results in increased expression of PPARG mRNA alternative form | CTD | PMID:16814746 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form | CTD | PMID:16814746 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of PPARG mRNA | CTD | PMID:19118567 PMID:14568882 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]; more ... | CTD | PMID:22197818 |
| dexamethasone | increases expression | ISO | RGD:69168 | 6480464 | Dexamethasone results in increased expression of PPARG protein; more ... | CTD | PMID:16569937 |
| dexamethasone | multiple interactions | ISO | RGD:69168 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA; more ... | CTD | PMID:19186324 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA | CTD | PMID:21350315 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of PPARG mRNA; more ... | CTD | PMID:14568882 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:16782535 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]; more ... | CTD | PMID:11101056 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:16054899 |
| dexamethasone | decreases expression | ISO | RGD:69169 | 6480464 | Dexamethasone results in decreased expression of PPARG mRNA | CTD | PMID:16889531 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:9543393 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | [caprylic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form; more ... | CTD | PMID:14984747 |
| dexamethasone | multiple interactions | ISO | RGD:69168 | 6480464 | [Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:20206132 |
| dexamethasone | multiple interactions | ISO | RGD:69169 | 6480464 | AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]; more ... | CTD | PMID:16971554 |
| dextran sulfate | increases expression | ISO | RGD:69169 | 6480464 | Dextran Sulfate results in increased expression of PPARG protein | CTD | PMID:23261717 |
| diarsenic trioxide | multiple interactions | ISO | RGD:69169 | 6480464 | arsenic trioxide inhibits the reaction [AKT1 protein binds to PPARG protein]; more ... | CTD | PMID:15916724 |
| diarsenic trioxide | decreases expression | ISO | RGD:69169 | 6480464 | arsenic trioxide results in decreased expression of PPARG protein | CTD | PMID:15916724 |
| diarsenic trioxide | decreases response to substance | ISO | RGD:69168 | 6480464 | PPARG protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| diazoxide | decreases expression | ISO | RGD:69169 | 6480464 | Isoproterenol results in decreased expression of PPARG mRNA | CTD | PMID:21854795 |
| diazoxide | multiple interactions | ISO | RGD:69169 | 6480464 | osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] | CTD | PMID:21854795 |
| diclofenac | increases activity | ISO | RGD:69168 | 6480464 | Diclofenac results in increased activity of PPARG protein | CTD | PMID:12065695 |
| didanosine | multiple interactions | ISO | RGD:69169 | 6480464 | Didanosine inhibits the reaction [Ritonavir results in increased expression of PPARG mRNA] | CTD | PMID:16822947 |
| diethylstilbestrol | increases expression | ISO | RGD:69169 | 6480464 | Diethylstilbestrol results in increased expression of PPARG mRNA; more ... | CTD | PMID:22710028 |
| diethylstilbestrol | multiple interactions | ISO | RGD:69169 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein]; more ... | CTD | PMID:22710028 |
| diethylstilbestrol | increases activity | ISO | RGD:69169 | 6480464 | Diethylstilbestrol results in increased activity of PPARG protein | CTD | PMID:22710028 |
| dimethyl sulfoxide | decreases expression | ISO | RGD:69168 | 6480464 | Dimethyl Sulfoxide results in decreased expression of PPARG mRNA | CTD | PMID:21878375 |
| dimethylarsinic acid | decreases expression | ISO | RGD:69168 | 6480464 | Cacodylic Acid results in decreased expression of PPARG mRNA | CTD | PMID:23221991 |
| dimethylarsinic acid | decreases expression | ISO | RGD:69169 | 6480464 | Cacodylic Acid results in decreased expression of PPARG mRNA | CTD | PMID:23221991 |
| dioxygen | decreases expression | ISO | RGD:69168 | 6480464 | Oxygen deficiency results in decreased expression of PPARG protein | CTD | PMID:19520921 |
| dioxygen | multiple interactions | ISO | RGD:69169 | 6480464 | [resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein | CTD | PMID:21113404 |
| dioxygen | increases expression | ISO | RGD:69169 | 6480464 | Oxygen deficiency results in increased expression of PPARG protein | CTD | PMID:21113404 |
| dioxygen | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form | CTD | PMID:16814746 |
| dioxygen | decreases expression | EXP | | 6480464 | Oxygen results in decreased expression of PPARG mRNA; more ... | CTD | PMID:16617452 |
| dioxygen | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]]; more ... | CTD | PMID:16617452 |
| dioxygen | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:21531777 |
| dioxygen | decreases expression | ISO | RGD:69169 | 6480464 | Oxygen deficiency results in decreased expression of PPARG protein; more ... | CTD | PMID:21531777 |
| disodium selenite | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA] | CTD | PMID:21705299 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of PPARG mRNA | CTD | PMID:21551480 |
| docetaxel anhydrous | multiple interactions | ISO | RGD:69169 | 6480464 | [celecoxib co-treated with docetaxel] results in increased expression of PPARG protein | CTD | PMID:16052515 |
| doxorubicin | multiple interactions | ISO | RGD:69168 | 6480464 | [nimesulide co-treated with Doxorubicin] results in increased expression of PPARG | CTD | PMID:14567645 |
| elemental selenium | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein]]; more ... | CTD | PMID:17439952 |
| enalapril | decreases expression | EXP | | 6480464 | Enalapril results in decreased expression of PPARG protein | CTD | PMID:19225048 |
| esculetin | multiple interactions | EXP | | 6480464 | esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein]; more ... | CTD | PMID:21450970 |
| ethanol | multiple interactions | ISO | RGD:69168 | 6480464 | Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]; more ... | CTD | PMID:17030193 |
| ethanol | multiple interactions | ISO | RGD:69169 | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] | CTD | PMID:18755807 |
| ethanol | increases expression | ISO | RGD:69169 | 6480464 | Ethanol results in increased expression of PPARG mRNA | CTD | PMID:18620774 more ... |
| ethanol | affects expression | ISO | RGD:69169 | 6480464 | Ethanol affects the expression of PPARG mRNA | CTD | PMID:19167417 |
| ethanol | increases expression | ISO | RGD:69169 | 6480464 | Ethanol results in increased expression of PPARG mRNA | CTD | PMID:20007851 PMID:18620774 |
| ethanol | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of PPARG mRNA] | CTD | PMID:22173916 |
| ethanol | multiple interactions | ISO | RGD:69169 | 6480464 | [rosiglitazone co-treated with Ethanol] results in increased expression of PPARG mRNA | CTD | PMID:20007851 |
| ethanol | increases expression | ISO | RGD:69169 | 6480464 | Ethanol results in increased expression of PPARG protein | CTD | PMID:20007851 |
| ethanol | decreases expression | ISO | RGD:69169 | 6480464 | Ethanol results in decreased expression of PPARG mRNA | CTD | PMID:22173916 |
| ethanol | increases expression | ISO | RGD:69169 | 6480464 | Ethanol results in increased expression of PPARG mRNA | CTD | PMID:18620774 PMID:20007851 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA; more ... | CTD | PMID:15318101 |
| ethanol | increases expression | ISO | RGD:69169 | 6480464 | Ethanol results in increased expression of PPARG mRNA | CTD | PMID:18620774 |
| eugenol | multiple interactions | ISO | RGD:69168 | 6480464 | Eugenol binds to and results in increased activity of PPARG protein; more ... | CTD | PMID:20064974 |
| eugenol | increases expression | ISO | RGD:69169 | 6480464 | Eugenol results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| eugenol | multiple interactions | ISO | RGD:69169 | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol binds to and results in increased activity of PPARG protein]; more ... | CTD | PMID:20064974 |
| fenofibrate | increases expression | ISO | RGD:69168 | 6480464 | Fenofibrate results in increased expression of PPARG mRNA | CTD | PMID:19201410 |
| fenofibrate | increases expression | ISO | RGD:69169 | 6480464 | Fenofibrate results in increased expression of PPARG mRNA | CTD | PMID:19201410 |
| fenoprofen | multiple interactions | ISO | RGD:69168 | 6480464 | Fenoprofen binds to and results in increased activity of PPARG protein | CTD | PMID:9013583 |
| ferulic acid | increases expression | ISO | RGD:69169 | 6480464 | ferulic acid results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| flavanone | increases expression | ISO | RGD:69168 | 6480464 | flavanone results in increased expression of PPARG protein | CTD | PMID:22056764 |
| fluconazole | increases expression | EXP | | 6480464 | Fluconazole results in increased expression of PPARG mRNA | CTD | PMID:20623750 |
| flufenamic acid | multiple interactions | ISO | RGD:69168 | 6480464 | Flufenamic Acid binds to and results in increased activity of PPARG protein | CTD | PMID:9013583 |
| flufenamic acid | multiple interactions | ISO | RGD:69168 | 6480464 | [Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein | CTD | PMID:10866999 |
| flufenamic acid | increases activity | ISO | RGD:69168 | 6480464 | Flufenamic Acid results in increased activity of PPARG protein | CTD | PMID:10866999 |
| fluprostenol | multiple interactions | ISO | RGD:69169 | 6480464 | fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA] | CTD | PMID:21236357 |
| fomepizole | multiple interactions | ISO | RGD:69168 | 6480464 | fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]] | CTD | PMID:17030193 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of PPARG mRNA | CTD | PMID:19196556 |
| fructose | multiple interactions | EXP | | 6480464 | rosiglitazone promotes the reaction [Fructose results in increased expression of PPARG mRNA] | CTD | PMID:19196556 |
| fucoxanthin | decreases expression | ISO | RGD:69169 | 6480464 | fucoxanthin results in decreased expression of PPARG mRNA | CTD | PMID:20519145 |
| fulvestrant | multiple interactions | ISO | RGD:69169 | 6480464 | fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein] | CTD | PMID:22710028 |
| gamma-linolenic acid | multiple interactions | ISO | RGD:69168 | 6480464 | gamma-Linolenic Acid binds to and results in increased activity of PPARG protein | CTD | PMID:15318936 |
| gemfibrozil | increases expression | ISO | RGD:69168 | 6480464 | Gemfibrozil results in increased expression of PPARG mRNA | CTD | PMID:19201410 |
| gemfibrozil | increases expression | ISO | RGD:69169 | 6480464 | Gemfibrozil results in increased expression of PPARG mRNA | CTD | PMID:19201410 |
| genistein | decreases expression | ISO | RGD:69169 | 6480464 | Genistein results in decreased expression of PPARG mRNA | CTD | PMID:18359623 |
| genistein | decreases expression | ISO | RGD:69168 | 6480464 | Genistein results in decreased expression of PPARG mRNA | CTD | PMID:20706672 |
| genistein | increases activity | EXP | | 6480464 | Genistein results in increased activity of PPARG protein | CTD | PMID:19903033 |
| genistein | multiple interactions | EXP | | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Genistein results in increased activity of PPARG protein]; more ... | CTD | PMID:19903033 |
| glucose | multiple interactions | EXP | | 6480464 | [ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose | CTD | PMID:18063688 |
| glucose | decreases expression | ISO | RGD:69168 | 6480464 | Glucose results in decreased expression of PPARG protein | CTD | PMID:21333731 |
| glucose | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] | CTD | PMID:21333731 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of PPARG protein; more ... | CTD | PMID:19609456 |
| glucose | multiple interactions | EXP | | 6480464 | PPARG protein inhibits the reaction [Glucose results in increased secretion of INS1 protein] | CTD | PMID:15878969 |
| glycerol | multiple interactions | EXP | | 6480464 | ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein] | CTD | PMID:16820301 |
| glycerol | decreases expression | EXP | | 6480464 | Glycerol results in decreased expression of PPARG protein | CTD | PMID:16820301 |
| glycerol 2-phosphate | multiple interactions | ISO | RGD:69169 | 6480464 | SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]] | CTD | PMID:14505802 |
| griseofulvin | increases expression | ISO | RGD:69169 | 6480464 | Griseofulvin results in increased expression of PPARG mRNA | CTD | PMID:9548566 |
| harmine | multiple interactions | ISO | RGD:69169 | 6480464 | [phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA | CTD | PMID:20519739 |
| heptadecafluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA | CTD | PMID:19196829 |
| heptadecafluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA | CTD | PMID:19196829 PMID:19878704 |
| heptadecafluorononanoic acid | increases expression | EXP | | 6480464 | perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA | CTD | PMID:19878704 PMID:19196829 |
| hydrazine | decreases expression | EXP | | 6480464 | hydrazine results in decreased expression of PPARG mRNA | CTD | PMID:15370871 |
| hydrogen peroxide | affects expression | ISO | RGD:69168 | 6480464 | Hydrogen Peroxide affects the expression of PPARG mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | affects abundance | ISO | RGD:69169 | 6480464 | PPARG protein affects the abundance of Hydrogen Peroxide | CTD | PMID:18083318 |
| hydrogen peroxide | decreases abundance | ISO | RGD:69169 | 6480464 | PPARG gene polymorphism results in decreased abundance of Hydrogen Peroxide | CTD | PMID:18083318 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] | CTD | PMID:17302992 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of PPARG protein | CTD | PMID:17302992 |
| hydrogen peroxide | multiple interactions | ISO | RGD:69168 | 6480464 | Hydrogen Peroxide results in increased phosphorylation of and results in decreased activity of PPARG protein | CTD | PMID:17030193 |
| hydroxytyrosol | decreases expression | ISO | RGD:69169 | 6480464 | 3,4-dihydroxyphenylethanol results in decreased expression of PPARG mRNA | CTD | PMID:21569430 |
| ibuprofen | multiple interactions | ISO | RGD:69169 | 6480464 | Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA] | CTD | PMID:16407166 |
| ibuprofen | increases expression | ISO | RGD:69169 | 6480464 | Ibuprofen results in increased expression of PPARG mRNA | CTD | PMID:16407166 |
| ibuprofen | increases activity | EXP | | 6480464 | Ibuprofen analog results in increased activity of PPARG protein | CTD | PMID:11755111 |
| ibuprofen | multiple interactions | ISO | RGD:69169 | 6480464 | Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein] | CTD | PMID:18946735 |
| ibuprofen | multiple interactions | ISO | RGD:69168 | 6480464 | Ibuprofen binds to and results in increased activity of PPARG protein | CTD | PMID:9013583 |
| imatinib | multiple interactions | ISO | RGD:69168 | 6480464 | imatinib inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein] | CTD | PMID:17030193 |
| indinavir | decreases expression | ISO | RGD:69169 | 6480464 | Indinavir results in decreased expression of PPARG mRNA | CTD | PMID:17926646 |
| indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of PPARG mRNA | CTD | PMID:21396975 |
| indomethacin | multiple interactions | ISO | RGD:69168 | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Indomethacin results in increased activity of PPARG protein] | CTD | PMID:12485869 |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:12065695 more ... |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:12485869 more ... |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:15899809 more ... |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:12485869 more ... |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:17602619 more ... |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:15899809 more ... |
| indomethacin | increases activity | EXP | | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:11755111 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein] | CTD | PMID:12897060 |
| indomethacin | increases activity | ISO | RGD:69169 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:11683414 |
| indomethacin | increases expression | ISO | RGD:69168 | 6480464 | Indomethacin results in increased expression of PPARG protein | CTD | PMID:17341418 |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin results in increased activity of PPARG protein | CTD | PMID:12065695 more ... |
| indomethacin | multiple interactions | ISO | RGD:69168 | 6480464 | Indomethacin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA] | CTD | PMID:16407166 |
| indomethacin | increases expression | ISO | RGD:69168 | 6480464 | Indomethacin results in increased expression of PPARG mRNA | CTD | PMID:12483719 |
| indomethacin | multiple interactions | ISO | RGD:69168 | 6480464 | [Indomethacin co-treated with L 663536] affects the localization of PPARG protein; more ... | CTD | PMID:15899809 |
| indomethacin | increases activity | ISO | RGD:69168 | 6480464 | Indomethacin analog results in increased activity of PPARG protein | CTD | PMID:17602619 |
| indomethacin | multiple interactions | ISO | RGD:69168 | 6480464 | [Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:20206132 |
| indomethacin | multiple interactions | ISO | RGD:69168 | 6480464 | Indomethacin binds to and results in increased activity of PPARG protein; more ... | CTD | PMID:9013583 |
| indomethacin | affects localization | ISO | RGD:69168 | 6480464 | Indomethacin affects the localization of PPARG protein | CTD | PMID:15899809 |
| iprodione | increases activity | ISO | RGD:69168 | 6480464 | iprodione results in increased activity of PPARG protein | CTD | PMID:20143881 |
| iron atom | increases expression | ISO | RGD:69168 | 6480464 | Iron deficiency results in increased expression of PPARG mRNA | CTD | PMID:20368581 |
| isonicotinamide | decreases expression | ISO | RGD:69169 | 6480464 | isonicotinamide results in decreased expression of PPARG mRNA | CTD | PMID:16813520 |
| isoprenaline | decreases expression | ISO | RGD:69169 | 6480464 | Isoproterenol results in decreased expression of PPARG mRNA | CTD | PMID:21854795 |
| isoprenaline | multiple interactions | ISO | RGD:69169 | 6480464 | osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA] | CTD | PMID:21854795 |
| isotretinoin | increases expression | EXP | | 6480464 | Isotretinoin results in increased expression of PPARG mRNA | CTD | PMID:19041696 |
| kaempferol | multiple interactions | ISO | RGD:69169 | 6480464 | kaempferol binds to and results in increased activity of PPARG protein | CTD | PMID:18262572 PMID:11343698 |
| kaempferol | multiple interactions | ISO | RGD:69169 | 6480464 | kaempferol binds to and results in increased activity of PPARG protein | CTD | PMID:11343698 PMID:18262572 |
| kaempferol | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; more ... | CTD | PMID:11343698 |
| kaempferol | multiple interactions | ISO | RGD:69169 | 6480464 | kaempferol inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein] | CTD | PMID:18262572 |
| L-ascorbic acid | multiple interactions | ISO | RGD:69169 | 6480464 | SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]] | CTD | PMID:14505802 |
| L-methionine | multiple interactions | ISO | RGD:69169 | 6480464 | [Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA; more ... | CTD | PMID:18991162 |
| lead(0) | increases expression | EXP | | 6480464 | Lead results in increased expression of PPARG mRNA | CTD | PMID:23086611 |
| lead(0) | increases expression | ISO | RGD:69169 | 6480464 | Lead results in increased expression of PPARG | CTD | PMID:23086611 |
| losartan | multiple interactions | EXP | | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of PPARG mRNA] | CTD | PMID:19109942 |
| losartan | multiple interactions | ISO | RGD:69169 | 6480464 | Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA] | CTD | PMID:18302760 |
| lovastatin | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein affects the reaction [Lovastatin results in increased expression of PTEN protein] | CTD | PMID:16425225 |
| lovastatin | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein] | CTD | PMID:16425225 |
| LY294002 | increases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA; more ... | CTD | PMID:17372590 |
| m-xylene | decreases expression | EXP | | 6480464 | 3-xylene results in decreased expression of PPARG mRNA | CTD | PMID:12815608 |
| manganese atom | multiple interactions | EXP | | 6480464 | [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18041089 |
| manganese(0) | multiple interactions | EXP | | 6480464 | [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18041089 |
| melatonin | decreases expression | ISO | RGD:69168 | 6480464 | Melatonin results in decreased expression of PPARG mRNA | CTD | PMID:20738756 |
| mercury dichloride | decreases expression | ISO | RGD:69169 | 6480464 | Mercuric Chloride results in decreased expression of PPARG protein | CTD | PMID:12883084 |
| mercury dichloride | decreases expression | ISO | RGD:69169 | 6480464 | Mercuric Chloride results in decreased expression of PPARG mRNA | CTD | PMID:22019852 |
| metformin | decreases expression | ISO | RGD:69168 | 6480464 | Metformin results in decreased expression of PPARG mRNA | CTD | PMID:20956498 |
| metformin | increases expression | ISO | RGD:69169 | 6480464 | Metformin results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| metformin | increases expression | EXP | | 6480464 | Metformin results in increased expression of PPARG mRNA | CTD | PMID:20724125 |
| methamphetamine | multiple interactions | ISO | RGD:69169 | 6480464 | 2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine]; more ... | CTD | PMID:17019405 |
| methamphetamine | increases response to substance | ISO | RGD:69169 | 6480464 | PPARG protein results in increased susceptibility to Methamphetamine | CTD | PMID:17019405 |
| methamphetamine | increases activity | ISO | RGD:69169 | 6480464 | Methamphetamine results in increased activity of PPARG protein | CTD | PMID:17019405 |
| methamphetamine | increases expression | ISO | RGD:69169 | 6480464 | Methamphetamine results in increased expression of PPARG protein | CTD | PMID:17019405 |
| methamphetamine | decreases expression | ISO | RGD:69169 | 6480464 | Methamphetamine results in decreased expression of PPARG protein | CTD | PMID:18946735 |
| methamphetamine | multiple interactions | ISO | RGD:69169 | 6480464 | Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein] | CTD | PMID:18946735 |
| mifepristone | multiple interactions | ISO | RGD:69169 | 6480464 | Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] | CTD | PMID:22956630 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:69168 | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; more ... | CTD | PMID:12927354 |
| mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA | CTD | PMID:23118965 |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:10581215 more ... |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:10581215 more ... |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:21561829 more ... |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69169 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:15322177 PMID:10581215 |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:12927354 more ... |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:21561829 more ... |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:12927354 PMID:10581215 |
| mono(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein; more ... | CTD | PMID:15647598 |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69169 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:10581215 PMID:15322177 |
| mono(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein | CTD | PMID:16326050 |
| mono(2-ethylhexyl) phthalate | increases activity | ISO | RGD:69168 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein | CTD | PMID:10581215 PMID:12927354 |
| N-acetyl-L-cysteine | increases expression | EXP | | 6480464 | Acetylcysteine results in increased expression of PPARG protein; more ... | CTD | PMID:17602960 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69169 | 6480464 | Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein] | CTD | PMID:22046279 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:69168 | 6480464 | Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein] | CTD | PMID:16945329 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]; more ... | CTD | PMID:17602960 |
| N-methyl-N-nitrosurea | increases response to substance | ISO | RGD:69169 | 6480464 | PPARG gene mutant form results in increased susceptibility to Methylnitrosourea | CTD | PMID:15930296 |
| N-nitrosodiethylamine | decreases response to substance | ISO | RGD:69169 | 6480464 | PPARG protein results in decreased susceptibility to Diethylnitrosamine | CTD | PMID:20512989 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of PPARG mRNA | CTD | PMID:15099470 |
| N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of PPARG mRNA | CTD | PMID:12055599 PMID:15099470 |
| naproxen | increases activity | EXP | | 6480464 | Naproxen results in increased activity of PPARG protein | CTD | PMID:11755111 |
| nevirapine | increases expression | ISO | RGD:69168 | 6480464 | Nevirapine results in increased expression of PPARG mRNA | CTD | PMID:21619898 |
| nickel sulfate | increases expression | ISO | RGD:69168 | 6480464 | nickel sulfate results in increased expression of PPARG mRNA | CTD | PMID:16314067 |
| nicotinamide | increases expression | ISO | RGD:69169 | 6480464 | Niacinamide results in increased expression of PPARG protein | CTD | PMID:22539994 |
| nicotinamide | multiple interactions | ISO | RGD:69169 | 6480464 | resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]; more ... | CTD | PMID:22539994 |
| nicotinic acid | multiple interactions | ISO | RGD:69168 | 6480464 | 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Niacin results in increased activity of PPARG protein]; more ... | CTD | PMID:16386710 |
| nicotinic acid | increases expression | ISO | RGD:69168 | 6480464 | Niacin results in increased expression of PPARG mRNA | CTD | PMID:19131065 PMID:15037193 |
| nicotinic acid | multiple interactions | ISO | RGD:69168 | 6480464 | Niacin results in increased expression of and results in increased activity of PPARG protein | CTD | PMID:15037193 PMID:16386710 |
| nicotinic acid | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein promotes the reaction [Niacin results in increased expression of ABCA1 mRNA]; more ... | CTD | PMID:19797938 |
| nicotinic acid | increases expression | ISO | RGD:69169 | 6480464 | Niacin results in increased expression of PPARG mRNA | CTD | PMID:19797938 |
| nicotinic acid | multiple interactions | ISO | RGD:69169 | 6480464 | fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA]; more ... | CTD | PMID:21236357 |
| nicotinic acid | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [Niacin results in increased expression of NR1H3 mRNA] | CTD | PMID:15037193 |
| nicotinic acid | increases expression | ISO | RGD:69168 | 6480464 | Niacin results in increased expression of PPARG mRNA | CTD | PMID:15037193 PMID:19131065 |
| nicotinic acid | multiple interactions | ISO | RGD:69168 | 6480464 | Niacin results in increased expression of and results in increased activity of PPARG protein | CTD | PMID:16386710 PMID:15037193 |
| nimesulide | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]]; more ... | CTD | PMID:15705899 |
| nimesulide | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG mutant form inhibits the reaction [nimesulide results in increased expression of PPARG mRNA] | CTD | PMID:15705899 PMID:15705899 |
| nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA] | CTD | PMID:19247274 |
| nimesulide | increases expression | ISO | RGD:69169 | 6480464 | nimesulide results in increased expression of PPARG mRNA | CTD | PMID:15705899 |
| nimesulide | multiple interactions | ISO | RGD:69169 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA] | CTD | PMID:15705899 |
| nimesulide | increases expression | ISO | RGD:69168 | 6480464 | nimesulide results in increased expression of PPARG protein | CTD | PMID:14977856 |
| nimesulide | decreases expression | ISO | RGD:69168 | 6480464 | nimesulide results in decreased expression of PPARG mRNA | CTD | PMID:11840453 |
| nimesulide | multiple interactions | ISO | RGD:69168 | 6480464 | nimesulide inhibits the reaction [ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]]; more ... | CTD | PMID:11840453 |
| nimesulide | multiple interactions | ISO | RGD:69168 | 6480464 | [nimesulide co-treated with Doxorubicin] results in increased expression of PPARG | CTD | PMID:14567645 |
| nitric oxide | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide | CTD | PMID:16527820 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18041089 |
| nitric oxide | increases expression | EXP | | 6480464 | Nitric Oxide deficiency results in increased expression of PPARG protein | CTD | PMID:17063326 |
| nitric oxide | multiple interactions | ISO | RGD:69169 | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]; more ... | CTD | PMID:12847270 |
| norathyriol | multiple interactions | ISO | RGD:69168 | 6480464 | norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein] | CTD | PMID:18393431 |
| o-cresol | increases expression | EXP | | 6480464 | 2-cresol results in increased expression of PPARG mRNA | CTD | PMID:21705299 |
| o-cresol | multiple interactions | EXP | | 6480464 | Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA] | CTD | PMID:21705299 |
| ochratoxin A | decreases expression | ISO | RGD:69168 | 6480464 | ochratoxin A results in decreased expression of PPARG | CTD | PMID:20590410 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of PPARG mRNA | CTD | PMID:15994020 |
| ochratoxin A | multiple interactions | EXP | | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]; more ... | CTD | PMID:15994020 |
| ochratoxin A | increases phosphorylation | ISO | RGD:69168 | 6480464 | ochratoxin A results in increased phosphorylation of PPARG protein | CTD | PMID:20590410 |
| ochratoxin A | decreases activity | ISO | RGD:69168 | 6480464 | ochratoxin A results in decreased activity of PPARG protein | CTD | PMID:20590410 |
| olanzapine | increases expression | ISO | RGD:69169 | 6480464 | olanzapine results in increased expression of PPARG protein alternative form | CTD | PMID:17651982 |
| oleic acid | increases expression | ISO | RGD:69169 | 6480464 | Oleic Acid results in increased expression of PPARG mRNA | CTD | PMID:18154422 |
| oleic acid | increases expression | ISO | RGD:69168 | 6480464 | Oleic Acid results in increased expression of PPARG mRNA; more ... | CTD | PMID:11172467 |
| oleoyl-CoA | multiple interactions | ISO | RGD:69168 | 6480464 | oleoyl-coenzyme A binds to and results in increased activity of PPARG protein | CTD | PMID:11139385 |
| ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of PPARG mRNA | CTD | PMID:16716893 |
| palmitic acid | increases expression | ISO | RGD:69169 | 6480464 | Palmitic Acid results in increased expression of PPARG mRNA | CTD | PMID:18154422 |
| palmitoyl-CoA | multiple interactions | ISO | RGD:69168 | 6480464 | Palmitoyl Coenzyme A binds to and results in increased activity of PPARG protein | CTD | PMID:11139385 |
| paracetamol | affects expression | ISO | RGD:69169 | 6480464 | Acetaminophen affects the expression of PPARG mRNA | CTD | PMID:17562736 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of PPARG mRNA | CTD | PMID:16701773 |
| paraquat | decreases response to substance | ISO | RGD:69169 | 6480464 | PPARG gene polymorphism results in decreased susceptibility to Paraquat | CTD | PMID:18083318 |
| paraquat | increases response to substance | ISO | RGD:69169 | 6480464 | PPARG protein results in increased susceptibility to Paraquat | CTD | PMID:18083318 |
| paricalcitol | multiple interactions | ISO | RGD:69168 | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein | CTD | PMID:17715259 |
| pentachloronitrobenzene | increases activity | ISO | RGD:69168 | 6480464 | quintozene results in increased activity of PPARG protein | CTD | PMID:20143881 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:69168 | 6480464 | perfluorooctane sulfonic acid results in increased expression of PPARG mRNA | CTD | PMID:22269386 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:69168 | 6480464 | perfluorooctanoic acid binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 |
| perfluorooctanoic acid | affects expression | ISO | RGD:69169 | 6480464 | perfluorooctanoic acid affects the expression of PPARG mRNA | CTD | PMID:22154759 |
| perfluorooctanoic acid | increases expression | ISO | RGD:69169 | 6480464 | perfluorooctanoic acid results in increased expression of PPARG mRNA | CTD | PMID:18281256 more ... |
| perfluorooctanoic acid | increases expression | ISO | RGD:69169 | 6480464 | perfluorooctanoic acid results in increased expression of PPARG protein | CTD | PMID:22154759 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:69169 | 6480464 | perfluorooctanoic acid results in decreased expression of PPARG mRNA | CTD | PMID:22154759 |
| perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | perfluorooctanoic acid binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:69169 | 6480464 | PPARA protein inhibits the reaction [perfluorooctanoic acid results in increased expression of PPARG mRNA] | CTD | PMID:18281256 |
| perfluorooctanoic acid | increases expression | ISO | RGD:69169 | 6480464 | perfluorooctanoic acid results in increased expression of PPARG mRNA | CTD | PMID:18281256 |
| perfluorooctanoic acid | multiple interactions | ISO | RGD:69169 | 6480464 | perfluorooctanoic acid binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 |
| phenobarbital | multiple interactions | ISO | RGD:69169 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPARG mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | ISO | RGD:69169 | 6480464 | Phenobarbital affects the expression of PPARG mRNA | CTD | PMID:23091169 |
| phenobarbital | affects expression | ISO | RGD:69168 | 6480464 | Phenobarbital affects the expression of PPARG mRNA | CTD | PMID:19159669 |
| phenobarbital | increases expression | ISO | RGD:69169 | 6480464 | Phenobarbital results in increased expression of PPARG mRNA | CTD | PMID:19482888 |
| phenol | increases expression | ISO | RGD:69168 | 6480464 | Phenol results in increased expression of PPARG mRNA | CTD | PMID:17547211 |
| phorbol 13-acetate 12-myristate | increases activity | ISO | RGD:69168 | 6480464 | Tetradecanoylphorbol Acetate results in increased activity of PPARG protein | CTD | PMID:15707588 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:69168 | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] affects the expression of PPARG mRNA | CTD | PMID:21511917 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:69168 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA | CTD | PMID:16945329 PMID:12044893 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:69168 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of PPARG protein | CTD | PMID:16945329 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:69168 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA | CTD | PMID:12044893 PMID:16945329 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of troglitazone]; more ... | CTD | PMID:16945329 |
| phosphorus atom | multiple interactions | ISO | RGD:69168 | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein | CTD | PMID:17715259 |
| phosphorus(.) | multiple interactions | ISO | RGD:69168 | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein | CTD | PMID:17715259 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | Ethanol inhibits the reaction [pioglitazone results in increased activity of PPARG protein] | CTD | PMID:17030193 |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA] | CTD | PMID:22989705 |
| pioglitazone | increases expression | ISO | RGD:69168 | 6480464 | pioglitazone results in increased expression of PPARG mRNA | CTD | PMID:11172467 more ... |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] | CTD | PMID:12055599 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone promotes the reaction [PPARG protein results in increased expression of PCSK9 mRNA] | CTD | PMID:22593575 |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15150131 more ... |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:11991651 more ... |
| pioglitazone | increases expression | ISO | RGD:69168 | 6480464 | pioglitazone results in increased expression of PPARG mRNA | CTD | PMID:11172467 PMID:19201410 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15729575 more ... |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:20064974 more ... |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:19403437 more ... |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16751799 more ... |
| pioglitazone | increases expression | ISO | RGD:69169 | 6480464 | pioglitazone results in increased expression of PPARG mRNA | CTD | PMID:16407166 more ... |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:17084873 more ... |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:9836514 more ... |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16751799 more ... |
| pioglitazone | increases expression | ISO | RGD:69169 | 6480464 | pioglitazone results in increased expression of PPARG mRNA | CTD | PMID:11991651 more ... |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:17084873 more ... |
| pioglitazone | affects binding | ISO | RGD:69168 | 6480464 | pioglitazone binds to PPARG protein | CTD | PMID:11779144 |
| pioglitazone | increases expression | ISO | RGD:69168 | 6480464 | pioglitazone results in increased expression of PPARG protein | CTD | PMID:11172467 |
| pioglitazone | increases expression | ISO | RGD:69168 | 6480464 | pioglitazone results in increased expression of PPARG mRNA | CTD | PMID:19201410 PMID:11172467 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone results in increased activity of [PPARG protein alternative form binds to RXRA protein] | CTD | PMID:11779144 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:9836514 more ... |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15150131 more ... |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:11991651 more ... |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:9836514 more ... |
| pioglitazone | increases expression | ISO | RGD:69169 | 6480464 | pioglitazone results in increased expression of PPARG mRNA | CTD | PMID:11991651 PMID:16407166 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:17084873 PMID:11991651 |
| pioglitazone | increases activity | ISO | RGD:69168 | 6480464 | pioglitazone results in increased activity of PPARG protein | CTD | PMID:17030193 PMID:16324916 |
| pioglitazone | increases expression | ISO | RGD:69168 | 6480464 | pioglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:20860658 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:20307981 more ... |
| pioglitazone | multiple interactions | EXP | | 6480464 | [pioglitazone results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides; more ... | CTD | PMID:19439812 |
| pioglitazone | increases activity | EXP | | 6480464 | pioglitazone results in increased activity of PPARG protein | CTD | PMID:19439812 |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA] | CTD | PMID:15318101 |
| pioglitazone | multiple interactions | EXP | | 6480464 | [pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Diglycerides]; more ... | CTD | PMID:19403437 |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:19403437 more ... |
| pioglitazone | increases expression | ISO | RGD:69169 | 6480464 | pioglitazone results in increased expression of PPARG mRNA | CTD | PMID:16407166 PMID:11991651 |
| pioglitazone | affects response to substance | ISO | RGD:69169 | 6480464 | PPARG protein affects the susceptibility to pioglitazone | CTD | PMID:16007095 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein affects the reaction [pioglitazone results in increased expression of ADIPOQ mRNA] | CTD | PMID:12927809 |
| pioglitazone | multiple interactions | EXP | | 6480464 | pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein] | CTD | PMID:16598202 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein] | CTD | PMID:17015710 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone promotes the reaction [PPARG protein binds to SCNN1G intron] | CTD | PMID:16007095 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [pioglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of RETSAT mRNA | CTD | PMID:19139408 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]; more ... | CTD | PMID:17019405 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:11991651 PMID:17084873 |
| pioglitazone | affects expression | ISO | RGD:69169 | 6480464 | pioglitazone affects the expression of PPARG mRNA | CTD | PMID:19048458 |
| pioglitazone | increases activity | ISO | RGD:69168 | 6480464 | pioglitazone results in increased activity of PPARG protein | CTD | PMID:16324916 PMID:17030193 |
| pioglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein] | CTD | PMID:15992368 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone promotes the reaction [PPARG protein binds to NPHS1 promoter] | CTD | PMID:16687628 |
| pioglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | pioglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:9836514 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]; more ... | CTD | PMID:11840453 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PPARG mRNA | CTD | PMID:22539621 |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid binds to and results in increased activity of PPARG protein | CTD | PMID:17610302 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid binds to and results in increased activity of PPARG protein | CTD | PMID:9013583 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid binds to and results in increased activity of PPARG protein | CTD | PMID:17610302 more ... |
| pirinixic acid | increases activity | ISO | RGD:69169 | 6480464 | pirinixic acid results in increased activity of PPARG protein | CTD | PMID:12401884 PMID:9703482 |
| pirinixic acid | multiple interactions | ISO | RGD:69169 | 6480464 | pirinixic acid results in increased activity of [PPARG protein co-treated with RXRA protein] | CTD | PMID:8700121 |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid binds to and results in increased activity of PPARG protein | CTD | PMID:18275039 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid binds to and results in increased activity of PPARG protein | CTD | PMID:9013583 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid binds to and results in increased activity of PPARG protein | CTD | PMID:18275039 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid analog binds to and results in increased activity of PPARG protein | CTD | PMID:18275039 PMID:20307981 |
| pirinixic acid | increases activity | ISO | RGD:69169 | 6480464 | pirinixic acid results in increased activity of PPARG protein | CTD | PMID:9703482 |
| pirinixic acid | multiple interactions | ISO | RGD:69169 | 6480464 | pirinixic acid promotes the reaction [PPARG protein binds to NFKBIA promoter]; more ... | CTD | PMID:19438714 |
| pirinixic acid | increases activity | ISO | RGD:69168 | 6480464 | pirinixic acid results in increased activity of PPARG protein | CTD | PMID:16386710 |
| pirinixic acid | increases expression | ISO | RGD:69168 | 6480464 | pirinixic acid results in increased expression of PPARG mRNA | CTD | PMID:11840453 |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA] | CTD | PMID:12604364 |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid binds to and results in increased activity of PPARG protein | CTD | PMID:9013583 more ... |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid analog binds to and results in increased activity of PPARG protein | CTD | PMID:20307981 PMID:18275039 |
| pirinixic acid | multiple interactions | ISO | RGD:69168 | 6480464 | pirinixic acid analog binds to and affects the activity of PPARG protein | CTD | PMID:17610302 |
| pravastatin | multiple interactions | ISO | RGD:69168 | 6480464 | Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol] | CTD | PMID:12044893 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of PPARG mRNA | CTD | PMID:16954335 |
| propylparaben | increases expression | ISO | RGD:69169 | 6480464 | propylparaben results in increased expression of PPARG mRNA | CTD | PMID:22956630 |
| prostaglandin F2alpha | multiple interactions | ISO | RGD:69169 | 6480464 | [Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA; more ... | CTD | PMID:21236357 |
| prostaglandin J2 | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 protein] | CTD | PMID:14662774 |
| prostaglandin J2 | increases expression | ISO | RGD:69168 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA | CTD | PMID:14512786 PMID:12595494 |
| prostaglandin J2 | multiple interactions | ISO | RGD:69168 | 6480464 | [9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]; more ... | CTD | PMID:12595494 |
| prostaglandin J2 | increases expression | ISO | RGD:69168 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA | CTD | PMID:12595494 PMID:14512786 |
| prostaglandin J2 | multiple interactions | EXP | | 6480464 | [9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter] | CTD | PMID:15150131 |
| prostaglandin J2 | multiple interactions | ISO | RGD:69168 | 6480464 | Ethanol inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein] | CTD | PMID:17030193 |
| prostaglandin J2 | increases activity | ISO | RGD:69168 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein | CTD | PMID:17030193 |
| prostaglandin J2 | multiple interactions | ISO | RGD:69168 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein | CTD | PMID:15491415 |
| prostaglandin J2 | increases expression | ISO | RGD:69168 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA | CTD | PMID:14512786 |
| prostaglandin J2 | multiple interactions | EXP | | 6480464 | 9-deoxy-delta-9-prostaglandin D2 promotes the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter] | CTD | PMID:12777391 |
| prostaglandin J2 | multiple interactions | ISO | RGD:69168 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein | CTD | PMID:11343236 PMID:15491415 |
| prostaglandin J2 | multiple interactions | ISO | RGD:69168 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein | CTD | PMID:15491415 PMID:11343236 |
| quercetin | multiple interactions | ISO | RGD:69168 | 6480464 | Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein] | CTD | PMID:18393431 |
| quercetin | multiple interactions | ISO | RGD:69169 | 6480464 | Quercetin binds to and results in increased activity of PPARG protein; more ... | CTD | PMID:18262572 |
| quinoline | multiple interactions | ISO | RGD:69168 | 6480464 | quinoline analog binds to and affects the activity of PPARG protein | CTD | PMID:17610302 |
| resmethrin | increases activity | ISO | RGD:69168 | 6480464 | resmethrin results in increased activity of PPARG protein | CTD | PMID:20143881 |
| resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:16849586 more ... |
| resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | [resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein | CTD | PMID:21113404 |
| resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG protein | CTD | PMID:18555852 more ... |
| resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 more ... |
| resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein] | CTD | PMID:22539994 |
| resveratrol | increases expression | ISO | RGD:69168 | 6480464 | resveratrol results in increased expression of PPARG protein | CTD | PMID:20709957 PMID:23041272 |
| resveratrol | increases expression | ISO | RGD:69168 | 6480464 | resveratrol results in increased expression of PPARG mRNA | CTD | PMID:23041272 |
| resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:16849586 more ... |
| resveratrol | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of PPARG mRNA]; more ... | CTD | PMID:23041272 |
| resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG protein | CTD | PMID:18555852 PMID:22935344 |
| resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 PMID:18555852 |
| resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] | CTD | PMID:18755807 |
| resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of PPARG protein]; more ... | CTD | PMID:18555852 |
| resveratrol | decreases expression | ISO | RGD:69168 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:20706672 PMID:21713995 |
| resveratrol | multiple interactions | ISO | RGD:69168 | 6480464 | resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein]; more ... | CTD | PMID:18776171 |
| resveratrol | increases expression | ISO | RGD:69168 | 6480464 | resveratrol results in increased expression of PPARG protein | CTD | PMID:20372816 more ... |
| resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol metabolite results in decreased expression of PPARG mRNA | CTD | PMID:22945685 |
| resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 more ... |
| resveratrol | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in increased expression of AGER protein]; more ... | CTD | PMID:20372816 |
| resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:17055343 PMID:16849586 |
| resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 |
| resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:16849586 PMID:17055343 |
| riddelliine | decreases expression | EXP | | 6480464 | riddelliine results in decreased expression of PPARG mRNA | CTD | PMID:18047727 |
| risperidone | increases expression | ISO | RGD:69169 | 6480464 | Risperidone results in increased expression of PPARG protein; more ... | CTD | PMID:20564506 |
| risperidone | multiple interactions | ISO | RGD:69169 | 6480464 | Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein]; more ... | CTD | PMID:20564506 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]; more ... | CTD | PMID:17030193 |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:18534569 more ... |
| rosiglitazone | increases activity | EXP | | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:19103650 PMID:22842585 |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:18534569 more ... |
| rosiglitazone | increases activity | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:18555852 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] | CTD | PMID:12055599 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:16344371 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:18278065 |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:18534569 more ... |
| rosiglitazone | increases activity | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:18555852 PMID:19417127 |
| rosiglitazone | decreases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in decreased expression of PPARG mRNA; more ... | CTD | PMID:18555852 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:16344371 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein]; more ... | CTD | PMID:18555852 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:15277403 more ... |
| rosiglitazone | affects response to substance | ISO | RGD:69168 | 6480464 | PPARG mRNA affects the susceptibility to rosiglitazone | CTD | PMID:17535976 PMID:20663321 |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:11779144 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:15277403 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | T 0070907 inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] | CTD | PMID:21354099 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased sumoylation of PPARG protein | CTD | PMID:22046279 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] | CTD | PMID:18949406 more ... |
| rosiglitazone | affects response to substance | ISO | RGD:69169 | 6480464 | PPARG affects the susceptibility to rosiglitazone | CTD | PMID:17463185 PMID:19075043 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:17030193 more ... |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:11779144 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]] | CTD | PMID:21333731 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:10871190 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:15277403 more ... |
| rosiglitazone | increases activity | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:12814394 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:10871190 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:17461532 more ... |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of PPARG mRNA | CTD | PMID:21515302 |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:20007851 more ... |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:19497422 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:19462893 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:18292206 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased susceptibility to rosiglitazone | CTD | PMID:17394460 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15254749 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:17461532 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:21373642 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15150131 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:20003221 more ... |
| rosiglitazone | increases activity | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:17030193 more ... |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:9013583 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]; more ... | CTD | PMID:21660147 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:10871190 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:18455351 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:20519551 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15150131 more ... |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:21392566 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:17030193 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:17030193 more ... |
| rosiglitazone | increases activity | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:20143881 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:20307981 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:16344371 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:17461532 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16751799 more ... |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:21392566 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:17726147 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:20506517 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:20003221 more ... |
| rosiglitazone | increases activity | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:17185614 more ... |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:12927354 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:20307981 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]; more ... | CTD | PMID:17461532 |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:21352814 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]; more ... | CTD | PMID:10871190 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:17726147 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG affects the reaction [rosiglitazone results in increased expression of PTEN protein] | CTD | PMID:16425225 |
| rosiglitazone | affects response to substance | ISO | RGD:69169 | 6480464 | PPARG affects the susceptibility to rosiglitazone | CTD | PMID:17463185 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:17461445 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG | CTD | PMID:17018897 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:19462893 more ... |
| rosiglitazone | increases activity | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:17185614 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA] | CTD | PMID:14625208 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone inhibits the reaction [[PPARG protein co-treated with RXRA protein] binds to SLC2A4 promoter] | CTD | PMID:12777391 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone binds to PPARG protein] which affects the localization of NCOA1 protein; more ... | CTD | PMID:10871190 |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:12927354 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:9836514 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein affects the reaction [rosiglitazone results in increased expression of PTEN protein] | CTD | PMID:16425225 |
| rosiglitazone | affects response to substance | ISO | RGD:69168 | 6480464 | PPARG gene polymorphism affects the susceptibility to rosiglitazone | CTD | PMID:16084854 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:18455351 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:21373642 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter] | CTD | PMID:12777391 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Glycosylation End Products, Advanced results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:17264099 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]]; more ... | CTD | PMID:16617452 |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:20007851 |
| rosiglitazone | increases expression | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:20007851 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:21531777 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of PPARG mRNA] | CTD | PMID:22173916 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:18991162 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA] | CTD | PMID:18302760 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA] | CTD | PMID:19147827 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [rosiglitazone co-treated with TNFSF11 protein] results in increased expression of PPARG mRNA | CTD | PMID:22286232 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [rosiglitazone co-treated with Ethanol] results in increased expression of PPARG mRNA | CTD | PMID:20007851 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG affects the reaction [rosiglitazone results in decreased expression of CX3CR1 mRNA] | CTD | PMID:19850645 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [RXRA co-treated with rosiglitazone] results in increased expression of PPARG mRNA | CTD | PMID:16213464 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:17461445 more ... |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:20860658 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:19462893 more ... |
| rosiglitazone | increases activity | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:17030193 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] | CTD | PMID:19186324 |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:9013583 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:19369484 more ... |
| rosiglitazone | affects localization | ISO | RGD:69168 | 6480464 | rosiglitazone affects the localization of PPARG protein | CTD | PMID:22321707 |
| rosiglitazone | affects response to substance | ISO | RGD:69168 | 6480464 | PPARG mRNA affects the susceptibility to rosiglitazone | CTD | PMID:20663321 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] | CTD | PMID:18949406 PMID:22321707 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide affects the reaction [rosiglitazone affects the localization of PPARG protein]; more ... | CTD | PMID:22321707 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:18455351 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:20519551 PMID:21373642 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Palmitates results in increased expression of PPARG mRNA] | CTD | PMID:16620699 |
| rosiglitazone | affects response to substance | EXP | | 6480464 | PPARG mRNA affects the susceptibility to rosiglitazone | CTD | PMID:20404217 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [T 0070907 binds to PPARG protein] which results in decreased susceptibility to rosiglitazone; more ... | CTD | PMID:18455351 |
| rosiglitazone | increases activity | EXP | | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:19103650 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:16344371 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone promotes the reaction [Fructose results in increased expression of PPARG mRNA] | CTD | PMID:19196556 |
| rosiglitazone | affects binding | EXP | | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:15726020 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of GFAP mRNA; more ... | CTD | PMID:18543250 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein] | CTD | PMID:12897060 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 more ... |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to rosiglitazone | CTD | PMID:19732122 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased activity of [RXRA protein binds to PPARG protein] | CTD | PMID:15997096 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]; more ... | CTD | PMID:19417127 |
| rosiglitazone | increases activity | ISO | RGD:69169 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:19417127 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone promotes the reaction [[PPARG protein binds to EDNRB promoter] which results in increased expression of EDNRB mRNA] | CTD | PMID:20516393 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein] | CTD | PMID:17015710 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of GDF15 mRNA; more ... | CTD | PMID:20512989 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:12758056 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | rosiglitazone binds to and affects the localization of PPARG protein | CTD | PMID:15174093 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | kaempferol inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]; more ... | CTD | PMID:18262572 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:16054899 |
| rosiglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [PPARG protein co-treated with RXRA protein] promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA]; more ... | CTD | PMID:16513826 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG protein | CTD | PMID:17461445 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone results in increased activity of PPARG protein] which results in increased abundance of Tretinoin | CTD | PMID:16982809 |
| rosiglitazone | increases expression | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased expression of PPARG mRNA | CTD | PMID:17030193 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]] | CTD | PMID:12927354 |
| rosiglitazone | increases activity | ISO | RGD:69168 | 6480464 | rosiglitazone results in increased activity of PPARG protein | CTD | PMID:17185614 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA; more ... | CTD | PMID:20206132 |
| rosiglitazone | affects binding | ISO | RGD:69168 | 6480464 | rosiglitazone binds to PPARG protein | CTD | PMID:9013583 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin; more ... | CTD | PMID:21781307 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | rosiglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:16731579 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide | CTD | PMID:16527820 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [rosiglitazone results in decreased expression of TPM3 protein alternative form] | CTD | PMID:19369484 |
| rosiglitazone | affects expression | ISO | RGD:69168 | 6480464 | rosiglitazone affects the expression of PPARG | CTD | PMID:15254749 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [rosiglitazone results in decreased expression of ICAM1 mRNA] | CTD | PMID:19417127 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [rosiglitazone results in decreased expression of FN1 protein] | CTD | PMID:15908479 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | Indomethacin inhibits the reaction [rosiglitazone binds to PPARG protein] | CTD | PMID:9013583 |
| rosiglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | diphenyltin chloride inhibits the reaction [rosiglitazone binds to PPARG protein]; more ... | CTD | PMID:19497422 |
| rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of PPARG mRNA; more ... | CTD | PMID:19693701 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:69169 | 6480464 | S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA] | CTD | PMID:21520053 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:69169 | 6480464 | Buthionine Sulfoximine results in increased expression of PPARG mRNA | CTD | PMID:21520053 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]; more ... | CTD | PMID:17602960 |
| salmeterol | multiple interactions | ISO | RGD:69168 | 6480464 | salmeterol promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]] | CTD | PMID:15531761 |
| selenium atom | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli 0111 B4 results in increased expression of PTGS2 protein]]; more ... | CTD | PMID:17439952 |
| sildenafil | increases expression | ISO | RGD:69169 | 6480464 | sildenafil results in increased expression of PPARG mRNA; more ... | CTD | PMID:20471953 |
| sildenafil | multiple interactions | ISO | RGD:69169 | 6480464 | 8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [sildenafil results in increased expression of PPARG protein] | CTD | PMID:20471953 |
| simvastatin | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA]; more ... | CTD | PMID:15781755 |
| simvastatin | decreases expression | EXP | | 6480464 | Simvastatin results in decreased expression of PPARG | CTD | PMID:19216230 |
| simvastatin | multiple interactions | ISO | RGD:69169 | 6480464 | Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:20835264 |
| sirolimus | affects expression | ISO | RGD:69168 | 6480464 | Sirolimus affects the expression of PPARG protein | CTD | PMID:17016853 |
| sirolimus | decreases expression | ISO | RGD:69169 | 6480464 | Sirolimus results in decreased expression of PPARG mRNA | CTD | PMID:15358118 |
| sirolimus | multiple interactions | ISO | RGD:69168 | 6480464 | [Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein; more ... | CTD | PMID:17016853 |
| sodium atom | affects abundance | ISO | RGD:69169 | 6480464 | PPARG protein affects the abundance of Sodium | CTD | PMID:16007095 |
| stavudine | multiple interactions | ISO | RGD:69169 | 6480464 | Stavudine inhibits the reaction [Ritonavir results in increased expression of PPARG mRNA] | CTD | PMID:16822947 |
| stavudine | decreases expression | ISO | RGD:69169 | 6480464 | Stavudine results in decreased expression of PPARG protein | CTD | PMID:15722030 |
| stavudine | decreases expression | ISO | RGD:69169 | 6480464 | Stavudine results in decreased expression of PPARG mRNA | CTD | PMID:17926646 |
| stavudine | decreases expression | ISO | RGD:69168 | 6480464 | Stavudine results in decreased expression of PPARG mRNA | CTD | PMID:14518702 |
| stearic acid | multiple interactions | EXP | | 6480464 | stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein] | CTD | PMID:17302992 |
| stearoyl-CoA | multiple interactions | ISO | RGD:69168 | 6480464 | stearoyl-coenzyme A binds to and results in increased activity of PPARG protein | CTD | PMID:11139385 |
| streptozocin | multiple interactions | ISO | RGD:69169 | 6480464 | telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] | CTD | PMID:21381899 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of PPARG protein | CTD | PMID:21450970 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of PPARG protein | CTD | PMID:16980342 PMID:21450970 |
| streptozocin | multiple interactions | EXP | | 6480464 | esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]; more ... | CTD | PMID:21450970 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of PPARG mRNA | CTD | PMID:12967931 |
| streptozocin | multiple interactions | EXP | | 6480464 | Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA] | CTD | PMID:12967931 |
| streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of PPARG mRNA | CTD | PMID:20219977 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of PPARG protein | CTD | PMID:16980342 |
| streptozocin | multiple interactions | EXP | | 6480464 | INS protein promotes the reaction [Streptozocin results in increased expression of PPARG mRNA] | CTD | PMID:20219977 |
| streptozocin | decreases expression | ISO | RGD:69169 | 6480464 | Streptozocin results in decreased expression of PPARG protein | CTD | PMID:21381899 |
| sulfasalazine | increases expression | EXP | | 6480464 | Sulfasalazine results in increased expression of PPARG mRNA | CTD | PMID:19365232 |
| tacrolimus hydrate | multiple interactions | ISO | RGD:69168 | 6480464 | [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein | CTD | PMID:17016853 |
| tebufenpyrad | increases activity | ISO | RGD:69168 | 6480464 | 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased activity of PPARG protein | CTD | PMID:20143881 |
| telmisartan | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]; more ... | CTD | PMID:22124178 |
| telmisartan | multiple interactions | EXP | | 6480464 | telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein] | CTD | PMID:20888384 |
| telmisartan | increases expression | ISO | RGD:69169 | 6480464 | telmisartan results in increased expression of PPARG protein | CTD | PMID:20176998 |
| telmisartan | multiple interactions | ISO | RGD:69169 | 6480464 | telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein] | CTD | PMID:21381899 |
| telmisartan | increases activity | ISO | RGD:69168 | 6480464 | telmisartan results in increased activity of PPARG protein | CTD | PMID:22124178 |
| telmisartan | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]] | CTD | PMID:18158351 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:69168 | 6480464 | tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; more ... | CTD | PMID:20847119 |
| tert-butyl hydroperoxide | increases activity | ISO | RGD:69168 | 6480464 | tert-Butylhydroperoxide results in increased activity of PPARG protein | CTD | PMID:16417216 |
| testosterone | decreases expression | ISO | RGD:69168 | 6480464 | Testosterone results in decreased expression of PPARG mRNA | CTD | PMID:21632903 |
| testosterone | decreases expression | ISO | RGD:69169 | 6480464 | Testosterone results in decreased expression of PPARG mRNA | CTD | PMID:12960001 PMID:20844152 |
| testosterone | decreases expression | ISO | RGD:69169 | 6480464 | Testosterone results in decreased expression of PPARG protein | CTD | PMID:12960001 |
| testosterone | decreases expression | ISO | RGD:69169 | 6480464 | Testosterone results in decreased expression of PPARG mRNA | CTD | PMID:20844152 PMID:12960001 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] | CTD | PMID:18006644 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | pioglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:12055599 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PPARG mRNA | CTD | PMID:12055599 more ... |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PPARG mRNA | CTD | PMID:18006644 PMID:15876570 |
| tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PPARG mRNA | CTD | PMID:15876570 PMID:18006644 |
| tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of PPARG protein | CTD | PMID:15959796 |
| tetrachloromethane | multiple interactions | EXP | | 6480464 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA] | CTD | PMID:15876570 |
| thapsigargin | multiple interactions | ISO | RGD:69169 | 6480464 | Thapsigargin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] | CTD | PMID:19141685 |
| theophylline | increases expression | ISO | RGD:69168 | 6480464 | Theophylline results in increased expression of PPARG mRNA; more ... | CTD | PMID:16569937 |
| toluene 2,4-diisocyanate | multiple interactions | ISO | RGD:69169 | 6480464 | pioglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]; more ... | CTD | PMID:17015710 |
| toluene 2,4-diisocyanate | increases localization | ISO | RGD:69169 | 6480464 | Toluene 2,4-Diisocyanate results in increased localization of PPARG protein | CTD | PMID:17015710 |
| trans-4-coumaric acid | increases expression | ISO | RGD:69169 | 6480464 | 4-coumaric acid results in increased expression of PPARG mRNA | CTD | PMID:21870829 |
| trans-resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:16849586 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | [resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein | CTD | PMID:21113404 |
| trans-resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG protein | CTD | PMID:18555852 more ... |
| trans-resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein] | CTD | PMID:22539994 |
| trans-resveratrol | increases expression | ISO | RGD:69168 | 6480464 | resveratrol results in increased expression of PPARG protein | CTD | PMID:20709957 PMID:23041272 |
| trans-resveratrol | increases expression | ISO | RGD:69168 | 6480464 | resveratrol results in increased expression of PPARG mRNA | CTD | PMID:23041272 |
| trans-resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:16849586 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of PPARG mRNA]; more ... | CTD | PMID:23041272 |
| trans-resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG protein | CTD | PMID:18555852 PMID:22935344 |
| trans-resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 PMID:18555852 |
| trans-resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA] | CTD | PMID:18755807 |
| trans-resveratrol | multiple interactions | ISO | RGD:69169 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of PPARG protein]; more ... | CTD | PMID:18555852 |
| trans-resveratrol | decreases expression | ISO | RGD:69168 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:20706672 PMID:21713995 |
| trans-resveratrol | multiple interactions | ISO | RGD:69168 | 6480464 | resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein]; more ... | CTD | PMID:18776171 |
| trans-resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol metabolite results in decreased expression of PPARG mRNA | CTD | PMID:22945685 |
| trans-resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 more ... |
| trans-resveratrol | increases expression | ISO | RGD:69168 | 6480464 | resveratrol results in increased expression of PPARG protein | CTD | PMID:20372816 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in increased expression of AGER protein]; more ... | CTD | PMID:20372816 |
| trans-resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:17055343 PMID:16849586 |
| trans-resveratrol | decreases expression | ISO | RGD:69169 | 6480464 | resveratrol results in decreased expression of PPARG mRNA | CTD | PMID:16813520 |
| trans-resveratrol | increases activity | ISO | RGD:69168 | 6480464 | resveratrol results in increased activity of PPARG protein | CTD | PMID:16849586 PMID:17055343 |
| tributylstannane | multiple interactions | ISO | RGD:69168 | 6480464 | tributyltin binds to and results in increased activity of PPARG protein; more ... | CTD | PMID:19497422 |
| tributylstannane | increases expression | ISO | RGD:69169 | 6480464 | tributyltin results in increased expression of PPARG mRNA | CTD | PMID:23322813 |
| tributylstannane | multiple interactions | ISO | RGD:69169 | 6480464 | tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form] | CTD | PMID:22197818 |
| tributylstannane | increases activity | ISO | RGD:69168 | 6480464 | tributyltin results in increased activity of PPARG protein | CTD | PMID:21622945 |
| tributylstannane | increases expression | ISO | RGD:69169 | 6480464 | tributyltin results in increased expression of PPARG protein | CTD | PMID:21622945 |
| trichloroethene | multiple interactions | ISO | RGD:69169 | 6480464 | PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of PPARG mRNA] | CTD | PMID:20709644 |
| trichloroethene | increases expression | ISO | RGD:69169 | 6480464 | Trichloroethylene results in increased expression of PPARG mRNA | CTD | PMID:20709644 |
| triclosan | decreases expression | ISO | RGD:69169 | 6480464 | Triclosan results in decreased expression of PPARG mRNA | CTD | PMID:15707987 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased activity of PPARG protein] | CTD | PMID:15345676 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG mRNA]; more ... | CTD | PMID:23108036 |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11113387 more ... |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [troglitazone co-treated with Diethylstilbestrol] results in increased expression of PPARG protein | CTD | PMID:22710028 |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:10097144 more ... |
| troglitazone | increases activity | ISO | RGD:69169 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:11683414 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:10097144 more ... |
| troglitazone | increases activity | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:15345676 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:10871190 more ... |
| troglitazone | increases activity | ISO | RGD:69169 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:11683414 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:10662598 PMID:21515302 |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11113387 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:11172467 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:10097144 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:11162573 more ... |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:19248225 more ... |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:19122273 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:16374840 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:16374840 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:20860658 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:14618613 more ... |
| troglitazone | affects binding | ISO | RGD:69168 | 6480464 | troglitazone binds to PPARG protein | CTD | PMID:20008677 more ... |
| troglitazone | increases activity | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:21617575 more ... |
| troglitazone | affects binding | ISO | RGD:69168 | 6480464 | troglitazone binds to PPARG protein | CTD | PMID:20008677 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:18162602 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:14634802 more ... |
| troglitazone | increases activity | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:17409431 more ... |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11113387 more ... |
| troglitazone | increases activity | ISO | RGD:69169 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:18799549 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:11162573 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:9709955 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:11752099 PMID:10662598 |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:18704104 more ... |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11113387 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:9709955 more ... |
| troglitazone | decreases expression | ISO | RGD:69169 | 6480464 | troglitazone results in decreased expression of PPARG mRNA | CTD | PMID:16813520 PMID:12732648 |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:19577614 PMID:10871190 |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:20860658 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11172467 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15618651 more ... |
| troglitazone | increases activity | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:21617575 more ... |
| troglitazone | affects binding | ISO | RGD:69168 | 6480464 | troglitazone binds to PPARG protein | CTD | PMID:11779144 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:11916926 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:15824748 more ... |
| troglitazone | increases activity | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:16149072 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [troglitazone binds to PPARG protein] which affects the localization of NCOA1 protein; more ... | CTD | PMID:10871190 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of CDKN1B protein | CTD | PMID:11034103 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:11343236 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:10662598 PMID:11752099 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:10662598 |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:19248225 more ... |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:11752099 PMID:19682441 |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11752099 more ... |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [troglitazone results in increased activity of PPARG protein] which results in increased expression of CD36 mRNA; more ... | CTD | PMID:11089532 |
| troglitazone | increases activity | ISO | RGD:69169 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:18799549 more ... |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | troglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]; more ... | CTD | PMID:10871190 |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:10871190 PMID:19577614 |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:16149072 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:11752099 |
| troglitazone | increases activity | EXP | | 6480464 | troglitazone results in increased activity of PPARG protein alternative form | CTD | PMID:15211114 |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15150131 more ... |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 mRNA; more ... | CTD | PMID:11318962 |
| troglitazone | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; more ... | CTD | PMID:21153920 |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:19682441 PMID:11752099 |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11752099 more ... |
| troglitazone | increases activity | ISO | RGD:69169 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:12732648 more ... |
| troglitazone | decreases expression | ISO | RGD:69169 | 6480464 | troglitazone results in decreased expression of PPARG mRNA | CTD | PMID:12732648 PMID:16813520 |
| troglitazone | increases response to substance | ISO | RGD:69169 | 6480464 | PPARG protein results in increased susceptibility to troglitazone | CTD | PMID:15581905 |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein affects the reaction [troglitazone results in increased activity of CYP1A1 protein]; more ... | CTD | PMID:18308446 |
| troglitazone | increases phosphorylation | ISO | RGD:69168 | 6480464 | troglitazone results in increased phosphorylation of PPARG protein alternative form | CTD | PMID:12475986 |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:14634802 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:16981146 more ... |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA alternative form | CTD | PMID:11916926 PMID:20860658 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 mRNA]; more ... | CTD | PMID:21617575 |
| troglitazone | increases activity | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:21617575 more ... |
| troglitazone | decreases activity | ISO | RGD:69168 | 6480464 | troglitazone results in decreased activity of PPARG protein alternative form | CTD | PMID:12475986 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone promotes the reaction [PPARG protein results in increased activity of [PPARG protein binds to RXRA protein]] | CTD | PMID:15581905 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone promotes the reaction [PPARG protein binds to PRODH promoter]; more ... | CTD | PMID:16303758 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA] | CTD | PMID:16483873 |
| troglitazone | affects binding | ISO | RGD:69168 | 6480464 | troglitazone binds to PPARG protein | CTD | PMID:20008677 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein; more ... | CTD | PMID:14618613 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of Cholesterol; more ... | CTD | PMID:16946405 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:14618613 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol]; more ... | CTD | PMID:12044893 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein affects the reaction [troglitazone results in decreased expression of SPP1 mRNA] | CTD | PMID:11426586 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein affects the reaction [troglitazone results in increased expression of ICAM1 mRNA] | CTD | PMID:11401521 |
| troglitazone | affects response to substance | ISO | RGD:69168 | 6480464 | PPARG gene SNP affects the susceptibility to troglitazone | CTD | PMID:16249460 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of troglitazone]; more ... | CTD | PMID:16945329 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | [2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone affects the localization of CYCS protein]; more ... | CTD | PMID:22108328 |
| troglitazone | multiple interactions | EXP | | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:15150131 more ... |
| troglitazone | multiple interactions | EXP | | 6480464 | [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein; more ... | CTD | PMID:19248225 |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:19682441 |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | [troglitazone results in increased activity of PPARG protein] which results in increased expression of ERO1L mRNA | CTD | PMID:17452443 |
| troglitazone | increases expression | ISO | RGD:69169 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:11113387 PMID:19682441 |
| troglitazone | increases activity | ISO | RGD:69169 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:11683414 PMID:18799549 |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:19577614 |
| troglitazone | decreases expression | ISO | RGD:69169 | 6480464 | troglitazone results in decreased expression of PPARG mRNA | CTD | PMID:16813520 |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | troglitazone binds to and results in decreased activity of PPARG protein | CTD | PMID:16368784 |
| troglitazone | multiple interactions | ISO | RGD:69169 | 6480464 | PPARG protein promotes the reaction [troglitazone results in increased expression of PPARGC1A mRNA] | CTD | PMID:16513826 |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG mRNA | CTD | PMID:17143939 PMID:15824748 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of [PPARG protein binds to RXRA protein]; more ... | CTD | PMID:20008677 |
| troglitazone | increases expression | ISO | RGD:69168 | 6480464 | troglitazone results in increased expression of PPARG protein | CTD | PMID:17143939 |
| troglitazone | increases activity | ISO | RGD:69168 | 6480464 | troglitazone results in increased activity of PPARG protein | CTD | PMID:15345676 |
| troglitazone | affects binding | ISO | RGD:69168 | 6480464 | troglitazone binds to PPARG protein | CTD | PMID:15383218 more ... |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; more ... | CTD | PMID:20847119 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | troglitazone binds to and results in increased activity of PPARG protein | CTD | PMID:18162602 more ... |
| troglitazone | affects binding | ISO | RGD:69168 | 6480464 | troglitazone analog binds to PPARG protein | CTD | PMID:18665581 |
| troglitazone | increases response to substance | ISO | RGD:69168 | 6480464 | PPARG protein results in increased susceptibility to troglitazone | CTD | PMID:12824901 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | sulindac sulfide analog inhibits the reaction [troglitazone binds to PPARG protein] | CTD | PMID:18665581 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG protein promotes the reaction [troglitazone results in decreased expression of FN1 protein] | CTD | PMID:15908479 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | PPARG mutant form inhibits the reaction [troglitazone results in increased expression of VEGFA protein] | CTD | PMID:15705899 |
| troglitazone | multiple interactions | ISO | RGD:69168 | 6480464 | 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein results in increased susceptibility to troglitazone] | CTD | PMID:12824901 |
| tunicamycin | multiple interactions | ISO | RGD:69169 | 6480464 | Tunicamycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA] | CTD | PMID:19141685 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA] | CTD | PMID:23399309 |
| zidovudine | decreases expression | ISO | RGD:69169 | 6480464 | Zidovudine results in decreased expression of PPARG mRNA | CTD | PMID:17926646 |
| zidovudine | decreases expression | ISO | RGD:69169 | 6480464 | Zidovudine results in decreased expression of PPARG protein | CTD | PMID:15722030 |
| zinc atom | multiple interactions | ISO | RGD:69168 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA | CTD | PMID:18593933 |
| zinc atom | multiple interactions | ISO | RGD:69169 | 6480464 | [LDLR gene mutant form results in increased susceptibility to Zinc deficiency] which results in increased expression of PPARG mRNA | CTD | PMID:16140885 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of PPARG mRNA | CTD | PMID:20128680 |
| zinc protoporphyrin | multiple interactions | ISO | RGD:69168 | 6480464 | zinc protoporphyrin inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]; more ... | CTD | PMID:21660147 |
| zinc(0) | multiple interactions | ISO | RGD:69168 | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA | CTD | PMID:18593933 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of PPARG mRNA | CTD | PMID:20128680 |
| zinc(0) | multiple interactions | ISO | RGD:69169 | 6480464 | [LDLR gene mutant form results in increased susceptibility to Zinc deficiency] which results in increased expression of PPARG mRNA | CTD | PMID:16140885 |